Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3045684	s-afmakro	u/l (u/l)	2054	2528	0.00%
3045684	s-afmakro	— (—)	369	397	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dialysis, with operation codes

252

195

13.54

265.09

1.4

1.2

40.62

20.37

u/l

3.55

231

160

ILD medications: immunosuppressive drugs

581

1127

5.01

264.08

1.3

1.2

23.82

20.33

u/l

0.76

511

968

Diseases of liver

433

693

6.40

257.63

1.3

1.2

32.23

20.31

u/l

3.31

388

578

Chronic kidney disease

346

468

7.53

239.40

1.4

1.2

30.77

23.06

u/l

1.50

312

381

Nephropathy related operations

239

202

12.39

238.12

1.4

1.2

40.27

20.35

u/l

3.87

218

170

Renal failure

450

732

5.72

231.92

1.3

34.93

24.12

u/l

3.04

402

602

Care involving dialysis

175

108

17.12

208.82

1.4

1.1

26.95

17.65

u/l

1.45

161

Autoimmune diseases excluding thyroid diseases

767

1162

3.69

196.20

1.3

1.2

26.19

24.33

u/l

0.34

680

988

Autoimmune diseases excluding thyroid diseases, strict definition

743

1110

3.76

194.98

1.3

1.2

25.80

23.97

u/l

0.34

662

942

Anaemias

229

118

13.10

186.81

1.3

1.2

30.43

13.79

u/l

4.45

206

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

722

1522

3.43

182.07

1.3

1.2

29.14

22.83

u/l

2.15

638

1301

ILD medications

779

1284

3.35

173.51

1.3

1.2

26.23

21.74

u/l

1.18

673

1114

Transplanted organ and tissue status

171

141

12.64

172.90

1.4

1.1

29.58

22.13

u/l

0.64

158

119

Renal tubulo-interstitial diseases

647

1441

3.47

169.91

1.3

1.2

32.28

21.32

u/l

4.58

576

1221

First line medication for Crohn's disease

743

1221

3.34

164.32

1.3

1.2

27.30

21.22

u/l

1.80

643

1054

ILD medications: prednisolone, methylprednisolone, prednisone

734

1270

3.29

160.56

1.4

1.2

27.27

21.93

u/l

1.38

632

1100

Other bacterial diseases

677

1447

3.26

156.44

1.3

1.2

37.35

18.75

u/l

9.27

613

1215

Bacterial infection, other or unspecified

432

957

4.12

151.51

1.3

1.2

44.56

18.82

u/l

9.54

403

793

L04AD Calcineurin inhibitors

174

179

10.09

151.47

1.4

1.1

26.37

21.38

u/l

0.45

158

152

Other diseases of liver

230

338

6.99

148.87

1.3

1.2

31.81

19.42

u/l

1.74

206

288

Preparatory care for dialysis

113

21.37

148.60

1.4

1.2

24.17

20.80

u/l

0.31

103

Autoimmune diseases related-to ILD

610

1680

3.22

148.16

1.3

1.2

26.65

23.63

u/l

0.54

533

1444

Inflammatory bowel disease treatment related agents

754

1434

3.01

143.57

1.3

1.2

25.05

23.14

u/l

0.36

651

1243

ILD medications: azathioprine

177

208

8.70

138.83

1.3

1.1

27.55

18.86

u/l

0.82

156

174

IBD patients in KELA-register

244

411

6.05

137.96

1.4

1.2

20.77

18.87

u/l

0.18

204

353

Fibrosis and cirrhosis of liver

139

125

11.66

133.13

1.4

1.1

33.25

14.23

u/l

2.78

126

107

Inflammatory bowel disease, strict (require KELA)

244

430

5.78

131.64

1.4

1.2

20.77

19.59

u/l

0.10

204

373

Second line medication for Crohn's disease

442

1246

3.59

131.24

1.3

1.2

22.75

22.52

u/l

0.03

387

1058

Azathioprine

177

230

7.87

127.78

1.3

1.2

27.55

18.10

u/l

0.95

156

193

Heart failure, not strict

545

1161

3.27

126.16

1.3

1.2

31.99

21.67

u/l

3.73

485

973

Examination and observation for other reasons

457

739

3.79

125.77

1.2

21.09

24.11

u/l

0.69

414

630

Glomerular disorders in diseases classified elsewhere

159

186

8.82

125.42

1.5

1.2

32.32

25.31

u/l

0.68

152

153

L04AA Selective immunosuppressants

239

443

5.51

122.27

1.3

1.1

28.61

20.02

u/l

1.12

219

371

Mucosal proctocolitis

160

196

8.37

121.45

1.4

1.1

23.76

21.10

u/l

0.16

133

162

L04AX Other immunosuppressants

423

1223

3.49

120.88

1.2

22.81

22.75

u/l

0.01

371

1038

5-aminosalicylic acid

210

350

6.10

120.04

1.4

1.2

22.67

17.39

u/l

0.55

176

297

Dental caries

237

439

5.43

119.44

1.3

1.2

34.31

20.89

u/l

2.48

215

371

Extracorporeal dialysis

113

13.64

119.31

1.6

1.2

27.87

18.51

u/l

1.52

104

Inflammatory bowel disease

286

637

4.55

117.76

1.4

1.2

21.80

20.82

u/l

0.10

241

544

Kidney transplant status

107

14.28

115.85

1.4

1.2

22.64

16.84

u/l

0.77

Bacterial Sepsis

343

772

4.00

115.25

1.4

1.2

39.07

22.10

u/l

4.94

309

641

Glomerular diseases

197

324

6.21

114.32

1.4

1.2

30.95

22.46

u/l

1.34

186

269

Noninfective enteritis and colitis

363

985

3.72

114.00

1.4

1.2

23.83

21.77

u/l

0.26

309

831

Tramadol

530

1099

3.12

112.02

1.3

1.2

31.83

21.39

u/l

3.15

454

947

Budesonide

161

219

7.52

111.77

1.5

1.1

21.98

15.96

u/l

0.95

139

184

Septicaemia

306

712

4.18

111.77

1.3

1.2

35.80

20.21

u/l

5.12

274

576

Autoimmune diseases

655

1173

2.87

111.27

1.3

1.2

24.92

24.18

u/l

0.11

569

998

Polyarthropathies

483

1009

3.22

108.19

1.2

1.3

25.39

26.91

u/l

0.23

423

873

Implicit bacterial Sepsis

303

689

4.08

105.64

1.3

1.2

41.77

21.15

u/l

6.08

272

571

Dentinal caries

210

395

5.37

104.84

1.3

1.2

34.41

20.38

u/l

2.42

191

332

Explicit Sepsis

310

779

3.86

101.43

1.3

1.2

35.62

21.14

u/l

4.49

278

650

Persons encountering health services for specific procedures and health care

649

1543

2.62

99.65

1.3

1.2

27.05

22.52

u/l

1.07

579

1314

Other septicaemia

270

644

4.16

98.72

1.3

1.2

35.65

20.70

u/l

4.40

242

519

Used for control exclusion in common control thyroid runs

590

1061

2.83

98.09

1.3

1.2

25.44

24.48

u/l

0.13

515

901

Ulcerative colitis

221

467

4.80

97.20

1.4

1.2

22.74

20.25

u/l

0.22

183

396

GASTRO-related operations

440

655

3.39

96.61

1.2

1.1

22.91

15.52

u/l

1.96

388

534

Any gastric operation

440

655

3.39

96.61

1.2

1.1

22.91

15.52

u/l

1.96

388

534

Ulcer of lower limb, not elsewhere classified

155

239

6.64

95.95

1.3

1.2

37.68

20.54

u/l

3.85

142

196

Fever of other and unknown origin

353

995

3.31

91.48

1.4

1.2

37.62

20.17

u/l

5.91

320

842

Acute renal failure

175

320

5.56

90.89

1.3

49.02

21.97

u/l

4.34

160

258

Unspecified kidney failure

116

137

8.70

90.79

1.2

30.03

22.90

u/l

0.62

100

114

Any reimbursement code in KELA

287

321

4.50

90.07

1.2

1.1

22.26

17.89

u/l

0.53

250

273

Disorders resulting from impaired renal tubular function

15.63

88.52

1.4

1.2

21.04

17.68

u/l

0.32

Oral corticosteroids

598

1411

2.58

88.48

1.3

1.2

29.90

23.36

u/l

1.49

517

1221

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

176

332

5.39

88.37

1.4

1.2

21.17

20.45

u/l

0.05

146

283

Ulcerative colitis (strict definition, require KELA)

167

305

5.57

86.90

1.4

1.2

21.54

20.93

u/l

0.04

138

259

Reimbursement for rheumatic diseases

404

1383

2.94

86.86

1.2

22.11

22.61

u/l

0.06

361

1167

Abnormal findings on examination of blood, without diagnosis

318

882

3.41

86.15

1.3

1.2

30.07

27.13

u/l

0.37

281

747

Crohn disease

137

208

6.72

86.03

1.4

1.1

22.27

19.31

u/l

0.25

118

173

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

162

294

5.61

84.89

1.4

1.2

22.08

21.35

u/l

0.04

134

248

Cholangitis (primary sclerosing, PSC)

11.10

83.92

1.3

1.2

40.63

16.65

u/l

1.61

Aplastic and other anaemias

316

908

3.33

82.98

1.3

1.2

34.67

25.23

u/l

2.22

280

760

Implicit Sepsis

455

1284

2.77

82.95

1.3

1.2

37.58

21.40

u/l

5.70

403

1085

Dialysis

14.64

81.42

1.4

1.2

19.53

18.80

u/l

0.06

Disorders of parathyroid gland

198

437

4.55

81.12

1.3

1.2

15.69

22.20

u/l

1.69

171

359

Other anaemias

293

842

3.39

79.48

1.3

1.2

34.42

25.87

u/l

1.74

259

702

Influenza and pneumonia

601

1647

2.41

79.45

1.3

1.2

34.92

19.57

u/l

6.45

539

1408

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

540

1332

2.55

79.35

1.3

1.2

35.01

19.38

u/l

5.95

484

1134

540

1332

2.55

79.35

1.3

1.2

35.01

19.38

u/l

5.95

484

1134

Insulin, intermediate and long-acting

350

1141

3.03

79.35

1.3

1.2

34.23

23.78

u/l

2.89

314

967

Pneumonias (Asthma/COPD co-morbidities)

575

1640

2.44

79.13

1.3

1.2

35.58

19.80

u/l

6.40

514

1399

Other Crohn's disease

9.76

78.61

1.3

1.1

19.72

13.11

u/l

0.94

Other and unspecified anaemias

288

830

3.39

78.16

1.3

1.2

34.50

26.07

u/l

1.66

254

693

All pneumoniae

577

1651

2.42

78.15

1.3

1.2

35.45

19.98

u/l

6.20

516

1410

Metabolic disorders

562

1421

2.47

76.97

1.3

1.2

27.83

23.81

u/l

0.86

495

1214

Insulin, fast-acting

254

711

3.61

76.46

1.3

1.2

36.66

20.63

u/l

3.97

229

597

Heart failure,strict

327

733

3.25

76.43

1.2

34.74

21.71

u/l

3.64

286

607

Insulin, combination of fast acting with intermediate-acting or long-acting

381

1244

2.84

75.94

1.3

1.2

35.18

24.19

u/l

3.13

342

1057

Secondary hypertension

105

9.08

75.92

1.3

1.1

19.40

17.05

u/l

0.29

Hyperparathyroidism

176

378

4.68

74.74

1.3

1.2

14.50

22.42

u/l

2.06

152

315

Diabetic nephropathy, excluding more controls

150

224

5.71

74.69

1.4

1.2

33.00

28.98

u/l

0.31

139

188

Malaise and fatigue

315

842

3.14

72.90

1.2

28.17

20.71

u/l

2.26

270

713

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

555

1647

2.38

72.60

1.3

1.2

35.60

20.18

u/l

5.89

497

1404

Insulin, fast-acting or short human

256

747

3.46

72.35

1.3

1.2

36.38

21.49

u/l

3.57

231

626

Insulin medication

381

1185

2.77

71.02

1.3

1.2

35.18

23.50

u/l

3.48

342

1010

Heart failure and antihypertensive medication

201

298

4.51

71.01

1.2

32.80

20.15

u/l

2.90

178

239

Osteopathies and chondropathies

362

1233

2.81

70.86

1.3

1.2

26.65

22.91

u/l

0.72

318

1044

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

136

249

5.57

70.71

1.3

1.2

38.91

22.07

u/l

2.73

125

207

Other disorders of kidney and ureter

127

220

5.90

70.05

1.3

1.1

19.79

21.97

u/l

0.24

113

182

Ulcerative colitis, NAS

130

232

5.70

69.42

1.2

1.1

19.26

20.11

u/l

0.08

108

192

Diabetic nephropathy

153

312

4.94

69.14

1.4

1.2

34.21

30.96

u/l

0.27

142

264

Nonalcoholic fatty liver disease

112

174

6.61

68.99

1.2

1.1

28.99

17.68

u/l

0.93

147

Pneumonia, organism unspecified

508

1534

2.41

68.69

1.3

1.2

37.67

20.03

u/l

6.47

453

1304

Nutritional anaemias

321

1073

2.94

68.60

1.3

1.2

29.67

24.15

u/l

1.10

284

910

Type 1 diabetes

189

464

4.11

68.59

1.3

1.2

34.36

21.01

u/l

2.36

174

392

Certain infectious and parasitic diseases

535

1099

2.45

67.60

1.3

1.2

25.84

17.89

u/l

2.43

460

931

General symptoms and signs

583

1260

2.33

66.25

1.3

1.2

28.31

19.53

u/l

3.07

503

1082

Disorders of other endocrine glands

293

972

2.99

64.98

1.3

1.2

19.15

22.60

u/l

0.85

253

825

Disorders of gallbladder, biliary tract and pancreas

554

1581

2.27

63.80

1.3

1.2

31.34

23.39

u/l

1.96

481

1356

Chronic periodontitis

135

272

5.05

63.06

1.5

1.2

26.24

21.46

u/l

0.45

124

227

Diseases of oesophagus, stomach and duodenum

578

1582

2.23

62.94

1.3

1.2

23.00

24.88

u/l

0.40

496

1370

Condition for Implicit Sepsis (Organ dysfunction codes)

471

1443

2.38

62.45

1.3

1.2

36.64

20.64

u/l

5.65

416

1221

Iron deficiency anaemia

272

893

3.04

62.28

1.3

1.2

31.12

23.92

u/l

1.36

241

749

Heart failure, strict

345

907

2.76

61.16

1.2

34.72

24.84

u/l

2.43

300

766

Crohn's disease NAS

8.54

61.00

1.4

1.1

27.24

14.81

u/l

1.03

Abnormal serum enzyme levels

193

521

3.70

60.15

1.3

32.83

27.05

u/l

0.61

167

434

Type 1 diabetes, wide definition, subgroup 1

153

354

4.37

60.15

1.3

1.2

33.32

17.15

u/l

3.42

142

300

Ulcerative colitis (strict definition, all Crohn cases excluded)

124

242

5.20

60.06

1.3

1.1

19.83

21.15

u/l

0.07

102

204

Other and unspecified iron deficiency

218

657

3.35

58.72

1.3

1.2

29.26

22.61

u/l

1.23

194

542

Exposure to unspecified factor

519

1840

2.20

58.04

1.2

24.16

24.34

u/l

0.03

436

1607

Erysipelas

307

1023

2.76

57.79

1.3

1.2

35.07

20.40

u/l

3.88

270

847

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

516

1588

2.22

57.21

1.3

1.2

28.18

23.20

u/l

1.16

448

1363

All-cause Heart Failure

333

893

2.71

57.06

1.2

34.40

24.91

u/l

2.18

289

754

Other heart diseases

278

612

3.02

56.53

1.3

1.2

27.03

19.10

u/l

1.93

252

519

Other diseases of intestines

545

1460

2.18

55.63

1.3

1.2

27.55

21.88

u/l

1.17

468

1270

Diseases of arteries, arterioles and capillaries (FINNGEN)

174

302

4.07

55.59

1.3

1.2

25.07

20.86

u/l

0.52

152

248

Complications of surgical and medical care, not elsewhere classified

523

1742

2.16

55.24

1.3

1.2

29.99

23.70

u/l

1.54

453

1503

Opioids

504

1176

2.26

54.47

1.3

1.2

25.38

20.70

u/l

1.10

425

1021

Implicit viral Sepsis

134

303

4.48

54.41

1.3

1.2

40.34

19.21

u/l

2.99

123

252

Type 1 diabetes, wide definition

155

391

4.00

54.34

1.3

1.2

33.06

20.34

u/l

2.02

144

333

Viral Sepsis

134

305

4.45

53.96

1.3

1.2

40.34

19.11

u/l

3.02

123

254

Acute tubulo-interstitial nephritis

337

1183

2.54

53.75

1.3

1.2

31.38

20.32

u/l

3.05

294

995

Malignant neoplasm of breast, HER2-negative

338

965

2.60

53.64

1.2

16.63

24.65

u/l

2.00

297

825

Diseases of arteries, arterioles and capillaries

377

1159

2.44

53.10

1.3

1.2

32.12

25.02

u/l

1.48

331

982

Intestinal infectious diseases

492

1777

2.16

53.05

1.3

1.2

28.41

23.28

u/l

1.34

434

1524

Gastrointestinal diseases

286

478

3.01

52.84

1.2

23.91

16.42

u/l

1.28

250

407

Insulin, fast-acting (human)

112

224

5.06

52.76

1.4

1.1

34.92

22.24

u/l

1.18

102

185

Hypertensive diseases (excluding secondary)

296

606

2.86

52.60

1.3

1.2

20.72

19.24

u/l

0.23

261

515

Malignant neoplasm of breast

343

976

2.56

52.58

1.2

16.95

24.37

u/l

1.79

302

834

Direct fill therapy

115

237

4.93

52.35

1.4

1.2

35.40

25.04

u/l

0.78

102

204

Pain in limb

419

1317

2.31

52.00

1.2

28.04

24.65

u/l

0.57

360

1136

Codeine

471

1150

2.26

51.66

1.2

23.71

20.71

u/l

0.67

397

996

Sub-endpoint used in defining T1D endpoints

190

560

3.36

51.49

1.3

1.2

33.39

23.64

u/l

1.53

175

469

Infections, IBD-co-morbidities

111

149

5.48

50.69

1.3

29.49

24.63

u/l

0.36

130

Diarrhoea and gastroenteritis of presumed infectious origin

368

1421

2.36

50.59

1.3

1.2

27.96

22.41

u/l

1.21

323

1217

Persons encountering health services for other counselling and medical advice, not elsewhere classified

579

1616

2.05

50.55

1.3

1.2

24.48

24.51

u/l

0.01

521

1378

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

303

740

2.70

50.22

1.2

17.46

20.71

u/l

0.47

267

635

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

303

741

2.69

50.09

1.2

17.46

20.73

u/l

0.48

267

636

Hypertension, essential

409

998

2.35

49.48

1.3

1.2

24.01

22.39

u/l

0.24

360

852

Other inflammatory liver diseases

106

7.16

49.22

1.2

1.1

23.51

14.97

u/l

0.62

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

107

7.08

48.79

1.3

1.1

18.25

16.48

u/l

0.15

Gout, FINNGEN

170

495

3.47

48.47

1.3

34.07

29.01

u/l

0.52

150

410

Crohn disease (strict definition, require KELA, min 2 HDR)

7.39

47.96

1.3

1.1

18.88

16.82

u/l

0.16

Finngen Rheumatological endpoints

488

1301

2.15

47.93

1.2

21.40

25.13

u/l

0.93

420

1130

Hypertension

412

1017

2.30

47.59

1.3

1.2

23.51

22.21

u/l

0.20

364

871

Other disorders of skin and subcutaneous tissue

381

1551

2.26

47.39

1.3

1.2

27.96

24.27

u/l

0.76

329

1328

Cardiovascular diseases (excluding rheumatic etc)

317

709

2.59

47.24

1.3

1.2

21.69

18.29

u/l

0.62

285

608

Hypertensive diseases

411

1018

2.30

47.14

1.3

1.2

23.55

22.19

u/l

0.21

363

872

Pain in joint

308

797

2.57

46.94

1.2

20.44

24.02

u/l

0.60

266

685

Care involving use of rehabilitation procedures

337

1359

2.37

46.87

1.2

26.28

22.98

u/l

0.41

295

1147

Gout

170

455

3.44

46.72

1.3

34.07

30.92

u/l

0.27

150

380

Crohn's disease of small intestine

103

7.04

46.67

1.5

1.1

19.52

14.71

u/l

0.47

Benign neoplasm: Colon

262

740

2.73

46.60

1.2

29.71

21.38

u/l

1.19

218

624

Crohn disease (strict definition, require KELA)

101

7.09

46.25

1.3

1.2

18.88

16.92

u/l

0.15

Heart failure and bmi 25plus

207

454

3.17

46.22

1.2

34.70

25.54

u/l

1.35

176

382

Crohn's disease of large intestine

8.05

45.69

1.3

1.1

22.88

14.20

u/l

0.87

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

447

1223

2.17

45.53

1.3

1.2

26.62

22.44

u/l

0.72

394

1048

Adjustment and management of implanted device

122

295

4.18

45.49

1.2

33.97

24.14

u/l

1.51

111

243

Chronic hepatitis, not elsewhere classified

10.38

45.36

1.3

1.1

19.89

14.91

u/l

0.84

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

447

1225

2.17

45.34

1.3

1.2

26.62

22.43

u/l

0.72

394

1050

Malignant neoplasm, wide definition for exclusion

447

1226

2.16

45.25

1.3

1.2

26.62

22.42

u/l

0.73

394

1051

Benign neoplasm of colon, rectum, anus and anal canal

288

802

2.58

45.10

1.2

31.49

21.39

u/l

1.56

241

679

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

229

656

2.86

44.89

1.2

15.97

19.82

u/l

0.59

204

558

Malignant neoplasm

453

1265

2.13

44.31

1.3

1.2

26.21

22.60

u/l

0.61

396

1080

Other and unspecified polyneuropathies, also in other diseases

132

348

3.84

43.74

1.3

1.2

30.87

23.47

u/l

0.82

113

288

Endocrine, nutritional and metabolic diseases

384

846

2.32

43.73

1.3

1.2

22.24

20.98

u/l

0.17

339

720

Other arthritis (FG)

190

632

3.03

43.56

1.2

1.3

25.23

21.15

u/l

0.54

173

533

Complications of procedures, not elsewhere classified

414

1696

2.12

43.35

1.3

1.2

30.05

23.41

u/l

1.33

358

1463

Any event in cancer register

456

1290

2.11

43.16

1.3

1.2

27.65

21.78

u/l

1.07

398

1106

Amputation

160

5.40

42.97

1.4

1.3

41.94

23.34

u/l

2.08

137

Chronic periodontitis, complicated

164

5.35

42.92

1.5

1.2

30.82

20.48

u/l

0.83

140

Polyneuropathies and other disorders of the peripheral nervous system

143

407

3.55

42.34

1.3

1.2

31.74

22.09

u/l

1.34

123

335

Asthma, excluding more controls

364

841

2.32

41.99

1.3

1.2

27.74

15.78

u/l

2.82

314

711

Oedema, not elsewhere classified

186

621

3.00

41.93

1.3

1.2

35.25

20.13

u/l

2.13

157

520

Other heart diseases, wide

451

1354

2.07

41.60

1.3

1.2

26.19

21.67

u/l

1.22

398

1156

Codeine or tramadol medication

563

1620

1.93

41.53

1.2

23.36

25.07

u/l

0.36

476

1410

Other disorders of fluid, electrolyte and acid-base balance

181

580

3.04

41.25

1.2

30.56

23.59

u/l

0.99

155

471

Peripheral artery disease

242

740

2.65

41.20

1.3

33.69

26.42

u/l

1.32

219

620

Diseases of the digestive system

251

996

2.53

40.83

1.3

1.2

34.93

24.75

u/l

1.56

227

837

Diseases of pulp and periapical tissues

197

694

2.86

40.75

1.3

1.2

30.86

21.91

u/l

1.28

178

581

Cardiovascular diseases

274

574

2.61

40.73

1.2

21.50

17.81

u/l

0.56

246

491

Unspecified privation

172

5.08

40.64

1.2

37.09

17.83

u/l

1.58

145

Medical observation and evaluation for suspected diseases and conditions

339

742

2.35

39.90

1.3

1.2

21.54

24.06

u/l

0.48

296

633

Asthma, unspecified (mode), excluding more controls

254

787

2.55

39.80

1.3

1.2

23.90

16.04

u/l

1.76

217

663

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

324

1456

2.23

39.61

1.3

1.2

29.49

22.71

u/l

1.23

279

1241

Complications of medical and surgical care

379

1721

2.10

39.56

1.3

1.2

33.32

22.85

u/l

2.41

329

1475

Oxycodone

195

675

2.81

38.89

1.5

1.2

46.87

22.84

u/l

4.24

178

574

Peripheral artery operations in Hilmo

210

4.53

38.86

1.4

1.3

38.99

24.68

u/l

1.59

176

Other diseases of biliary tract

142

5.45

38.81

1.4

1.2

39.99

18.85

u/l

1.28

118

Disorders of lipoprotein metabolism and other lipidaemias

418

1273

2.07

38.67

1.2

25.99

24.39

u/l

0.24

366

1080

Bleeding

419

1505

2.03

38.11

1.3

1.2

30.60

23.88

u/l

1.54

369

1274

Pain, not elsewhere classified

159

516

3.11

38.11

1.3

1.2

31.61

19.05

u/l

1.69

143

432

Other specified/unspecified arthritis

167

558

3.02

38.07

1.2

1.3

21.28

22.87

u/l

0.21

153

473

Sulfasalazine

170

575

2.98

37.91

1.3

1.2

19.24

19.86

u/l

0.06

153

486

Continuous positive airway pressure

120

274

3.81

37.91

1.2

1.3

40.01

18.40

u/l

3.07

110

228

Gout, strict definition

110

284

3.92

37.61

1.2

1.3

31.60

23.90

u/l

0.81

232

Gout, idiopatic and unspecified

142

435

3.30

37.51

1.3

33.70

27.08

u/l

0.67

127

355

Other soft tissue disorders, not elsewhere classified

439

1352

2.01

37.45

1.2

25.51

24.30

u/l

0.17

378

1168

Glomerulonephritis

162

5.02

37.30

1.3

1.2

25.59

19.44

u/l

0.63

135

Infections of the skin and subcutaneous tissue

287

1258

2.28

37.24

1.3

1.2

30.63

22.97

u/l

1.65

257

1073

Diabetes, varying definitions

500

1562

1.92

36.99

1.3

1.2

26.95

22.61

u/l

1.10

442

1339

Gout, unspecified

121

338

3.62

36.91

1.3

33.12

24.67

u/l

0.86

109

272

Other specific joint derangements/joint disorders

344

1065

2.17

36.53

1.2

1.3

19.27

25.00

u/l

1.41

297

927

Asthma

374

937

2.15

36.41

1.3

1.2

27.46

17.71

u/l

2.10

323

796

L02BG Aromatase inhibitors

205

785

2.64

36.26

1.2

13.34

23.43

u/l

4.51

183

663

Bacterial pneumoniae

215

742

2.58

35.62

1.3

1.2

32.48

21.62

u/l

2.50

197

620

Atherosclerosis, excluding cerebral and coronary sclerosis

221

690

2.58

35.62

1.2

1.3

31.24

26.50

u/l

0.79

198

578

Diseases of the skin and subcutaneous tissue

483

1250

1.94

35.48

1.3

1.2

23.54

23.26

u/l

0.04

419

1070

Disorders of mineral metabolism

129

5.44

35.23

1.4

1.1

31.66

24.08

u/l

0.41

106

Explicit bacterial Sepsis

140

5.21

35.14

1.5

1.1

29.64

16.29

u/l

1.55

116

Rheumatoid arthritis

196

671

2.67

35.04

1.2

1.3

22.82

24.21

u/l

0.18

175

572

Bacterial pneumonia, not elsewhere classified

205

697

2.62

34.99

1.3

1.2

33.53

22.01

u/l

2.55

187

580

Asthma (only as main-diagnosis), excluding more controls

315

841

2.24

34.88

1.3

1.2

27.31

15.78

u/l

2.64

279

711

COPD/asthma related infections

505

1334

1.90

34.82

1.3

1.2

26.00

19.39

u/l

1.73

443

1136

COPD/asthma/ILD related infections

505

1334

1.90

34.82

1.3

1.2

26.00

19.39

u/l

1.73

443

1136

Hypothyroidism (congenital or acquired)

101

127

4.59

34.81

1.2

27.57

13.28

u/l

1.16

107

Persons encountering health services in other circumstances, wide

568

1622

1.82

34.74

1.3

1.2

25.76

24.47

u/l

0.23

509

1384

Osteoporosis

170

573

2.86

34.73

1.3

1.2

25.91

23.14

u/l

0.28

145

483

Diabetes mellitus

494

1570

1.88

34.63

1.2

27.10

22.56

u/l

1.16

437

1345

Deposits [accretions] on teeth

6.30

34.58

1.3

1.2

38.83

23.18

u/l

0.76

Chronic periapical parodontitis

130

397

3.31

34.55

1.3

1.2

29.45

21.36

u/l

0.86

119

331

Medicines for HER+ breast cancer

233

943

2.43

34.52

1.2

16.07

23.52

u/l

1.51

207

798

Chronic gastritis

170

608

2.82

34.31

1.2

29.27

25.93

u/l

0.35

143

512

Other noninfective gastroenteritis and colitis

148

490

3.04

34.29

1.3

1.2

26.86

21.53

u/l

0.62

126

410

Malignant neoplasm of breast, HER-positive

226

917

2.45

34.28

1.2

15.22

22.85

u/l

1.60

201

775

Asthma, unspecified (mode)

258

875

2.35

34.16

1.3

1.2

23.80

17.93

u/l

1.16

220

740

Hypothyroidism and >3 levothyroxin purchases

126

4.54

33.74

1.2

28.06

13.28

u/l

1.18

106

Hypothyroidism, levothyroxine purchases

126

4.54

33.74

1.2

28.06

13.28

u/l

1.18

106

Neoplasms

320

776

2.22

33.66

1.2

22.45

21.05

u/l

0.15

278

677

Covid-19 confirmed case

157

545

2.90

33.48

1.4

1.2

31.65

21.55

u/l

1.83

146

461

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

469

1524

1.89

33.19

1.3

1.2

31.30

22.92

u/l

2.35

413

1303

Other diseases of intestine

212

4.21

33.12

1.3

1.2

39.67

20.72

u/l

1.11

176

Certain disorders involving the immune mechanism

129

403

3.24

33.09

1.3

1.2

21.89

22.97

u/l

0.11

118

336

Streptococcal septicaemia

112

5.62

32.84

1.5

1.1

32.50

14.14

u/l

2.02

Diabetes medication

488

1624

1.83

31.60

1.3

1.2

31.00

22.40

u/l

2.51

428

1394

Ascites

120

5.35

31.56

1.3

1.2

46.29

20.31

u/l

1.60

100

Asthma (mode)

354

947

2.06

31.30

1.3

1.2

27.48

17.76

u/l

2.08

307

805

Diaphragmatic hernia

214

898

2.40

31.21

1.2

26.48

23.85

u/l

0.25

177

757

Spondyloarthritis

105

299

3.54

31.16

1.2

36.46

20.32

u/l

1.47

248

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

293

1399

2.10

31.14

1.3

1.2

30.55

23.05

u/l

1.25

251

1194

Benign neoplasms

313

826

2.15

31.13

1.2

22.81

21.05

u/l

0.22

265

718

Alcoholic liver disease

144

4.86

31.10

1.2

42.44

20.70

u/l

1.85

119

Acute peritonitis

5.88

31.05

1.3

1.2

26.52

17.15

u/l

0.93

Cutaneous abscess, furuncle and carbuncle

144

498

2.91

30.98

1.3

1.2

28.19

20.14

u/l

1.07

129

421

Diabetes, insulin treatment (Kela reimbursement)

486

1638

1.82

30.91

1.3

1.2

31.14

23.12

u/l

2.30

427

1401

Bacterial pneumonia (organism specified)

227

887

2.34

30.86

1.3

1.2

32.24

23.06

u/l

2.07

209

738

Cholelithiasis, broad definition with cholecystitis

414

1498

1.90

30.84

1.2

30.54

22.84

u/l

1.42

357

1282

Low back pain

347

1339

2.00

30.82

1.3

1.2

28.33

23.43

u/l

0.92

308

1158

Fall on same level

527

1656

1.78

30.67

1.3

1.2

26.07

22.89

u/l

0.68

450

1445

Haemorrhage from respiratory passages

183

666

2.57

30.36

1.2

34.77

23.98

u/l

1.60

158

563

Other retinal disorders

313

1225

2.06

30.32

1.3

1.2

29.39

25.46

u/l

0.59

263

1056

Artificial opening status

6.76

29.81

1.3

1.1

61.10

18.68

u/l

1.66

Cardiac arrhythmias

286

880

2.16

29.80

1.3

1.2

24.37

19.99

u/l

0.85

252

751

Crohn disease (strict definition, all UC cases excluded)

6.41

29.57

1.3

1.1

13.67

15.16

u/l

0.13

Statin medication

340

939

2.04

29.42

1.3

1.2

21.61

24.58

u/l

0.47

288

818

Viral pneumonia

188

4.19

29.36

1.3

1.2

29.71

17.83

u/l

1.49

157

Non-ischemic cardiomyopathy

163

497

2.71

29.33

1.2

1.3

29.84

24.73

u/l

0.64

141

417

Cholelithiasis

399

1487

1.89

29.32

1.2

30.03

22.44

u/l

1.37

341

1273

Asthma (only as main-diagnosis)

320

937

2.07

29.32

1.3

1.2

27.10

17.71

u/l

1.93

282

796

Atrial fibrillation and flutter

172

416

2.71

29.22

1.3

1.2

24.77

19.97

u/l

0.78

155

345

Asthma-related pneumonia or sepsis

191

785

2.45

29.08

1.3

1.2

39.03

23.42

u/l

1.74

167

656

Asthma, hospital admissions 3, pneumonia

191

785

2.45

29.08

1.3

1.2

39.03

23.42

u/l

1.74

167

656

Abnormalities of breathing

403

1266

1.90

28.97

1.2

30.32

22.83

u/l

1.72

351

1089

Biological medication for rheuma

102

300

3.44

28.88

1.1

1.2

20.00

22.78

u/l

0.24

256

Asthma-related pneumonia

190

784

2.44

28.69

1.3

1.2

39.04

23.44

u/l

1.73

166

655

Fracture of femur

142

460

2.84

28.58

1.3

1.2

29.29

26.31

u/l

0.23

124

381

Disorders of choroid and retina

386

1496

1.89

28.48

1.3

1.2

27.46

25.32

u/l

0.33

322

1292

Ulcerative rectosigmoiditis

120

5.07

28.44

1.5

1.1

28.76

16.37

u/l

0.47

Seropositive rheumatoid arthritis

152

571

2.68

27.88

1.2

22.17

21.20

u/l

0.12

137

487

GI-bleeding

164

643

2.57

27.71

1.2

34.70

27.55

u/l

0.69

148

533

Benign neoplasm of colon, rectum, anus and anal canal

304

1382

1.99

27.54

1.2

31.79

24.38

u/l

1.05

256

1179

Lower back pain or/and sciatica

466

1838

1.76

27.51

1.3

1.2

28.72

23.54

u/l

1.19

405

1586

Gingivitis and periodontal diseases

413

1144

1.87

27.46

1.3

1.2

24.61

24.42

u/l

0.02

357

975

Benign neoplasm of other and ill-defined parts of digestive system

102

310

3.32

27.44

1.3

1.2

26.18

21.39

u/l

0.48

256

Congenital malformations of the urinary system

5.71

27.44

1.4

1.2

26.68

16.32

u/l

1.08

Dyspnoea

414

1752

1.82

27.44

1.2

30.06

23.93

u/l

1.59

357

1505

Type 2 diabetes, wide definition

388

1355

1.87

27.43

1.3

1.2

29.41

22.68

u/l

1.57

339

1148

Nausea and vomiting

144

524

2.72

27.24

1.3

1.2

29.95

22.09

u/l

0.88

129

428

Benign neoplasm: Colon

265

1257

2.08

27.16

1.2

30.51

25.04

u/l

0.65

221

1073

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

215

583

2.35

27.12

1.3

1.2

25.59

19.48

u/l

0.98

184

493

Systemic connective tissue disorders

198

857

2.33

26.99

1.3

1.2

28.74

21.92

u/l

0.88

172

725

Antihypertensive medication - note that there are other indications

251

620

2.22

26.84

1.2

20.08

19.27

u/l

0.09

224

528

Other nutritional deficiencies

295

1457

1.99

26.84

1.3

1.2

20.70

22.56

u/l

0.41

252

1253

Adalimumab

138

4.63

26.83

1.2

1.1

17.66

17.36

u/l

0.02

117

Hyperkalaemia

6.40

26.57

1.3

1.1

38.13

20.83

u/l

1.03

Other diseases of the digestive system

162

645

2.53

26.54

1.2

34.64

27.38

u/l

0.71

148

534

Primary_lymphoid and hematopoietic malignant neoplasms

122

421

2.92

26.41

1.2

45.54

21.69

u/l

3.03

110

353

Codes for special purposes

211

947

2.24

26.36

1.4

1.2

29.36

21.50

u/l

1.83

197

798

Hypertensive heart and/or renal disease

131

353

2.90

26.30

1.2

1.3

34.34

22.94

u/l

1.95

120

295

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

100

4.83

26.27

1.1

1.3

44.02

20.88

u/l

1.39

Other ulcerative colitis

5.74

26.03

1.4

1.1

42.50

16.44

u/l

0.84

Asthma, hospital admission 2, infections

277

1364

2.01

25.95

1.3

1.2

32.67

22.84

u/l

1.47

245

1171

Asthma-related infections

277

1364

2.01

25.95

1.3

1.2

32.67

22.84

u/l

1.47

245

1171

241

3.56

25.51

1.3

1.1

26.28

22.18

u/l

0.26

206

Provisional assignment of new diseases of uncertain etiology

209

948

2.22

25.46

1.4

1.2

29.38

21.51

u/l

1.81

195

799

Speech therapy

157

629

2.52

25.45

1.2

26.49

21.56

u/l

0.41

132

526

Other diseases of blood and blood-forming organs, wide

131

480

2.75

25.43

1.2

33.02

23.09

u/l

1.03

118

399

Hernia of abdominal wall, postoperative

224

3.64

25.20

1.3

1.1

42.20

16.97

u/l

1.58

179

Hypothyroidism, drug reimbursement

4.82

25.18

1.2

32.75

13.30

u/l

1.44

Pleural effusion

282

3.33

25.16

1.2

48.93

24.42

u/l

1.49

232

Rheumatoid arthritis, including avohilmo

211

968

2.19

25.05

1.2

22.30

22.67

u/l

0.05

187

816

Depression

431

1698

1.75

24.94

1.2

25.32

22.82

u/l

0.42

371

1466

Tumor necrosis factor alpha inhibitors

264

3.41

24.93

1.1

1.2

18.71

23.01

u/l

0.39

226

Other bacterial intestinal infections

103

335

3.10

24.81

1.3

1.2

32.33

23.10

u/l

0.95

281

Pure hypercholesterolaemia

334

1185

1.90

24.80

1.3

1.2

27.49

24.59

u/l

0.41

292

1001

Cystic kidney disease

6.80

24.77

1.3

1.2

26.91

17.02

u/l

1.13

Excluding asthma or asthma-COPD overlap

358

948

1.90

24.75

1.2

25.47

17.59

u/l

1.70

310

807

Constipation

409

1659

1.77

24.72

1.3

1.2

24.62

25.08

u/l

0.06

350

1430

Diabetic retinopathy, excluding more controls

148

307

2.74

24.47

1.4

1.2

29.90

25.98

u/l

0.37

127

266

Spondylopathies

375

1249

1.83

24.34

1.2

29.17

24.77

u/l

0.65

320

1076

Pain in throat and chest

368

1227

1.84

24.31

1.2

23.58

23.12

u/l

0.06

319

1051

Diverticular disease of intestine

331

1167

1.89

24.26

1.2

25.25

23.00

u/l

0.35

280

1003

Type 2 diabetes

444

1521

1.74

24.21

1.2

27.91

23.07

u/l

1.13

391

1300

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

126

4.59

24.05

1.4

1.2

26.41

17.72

u/l

0.96

106

Viral pneumonia (unknown virus, not influenza)

5.29

23.91

1.3

1.2

38.81

16.36

u/l

2.25

UC patients in KELA-register (code 208), prior to 1994

5.77

23.88

1.6

1.2

11.41

17.11

u/l

1.23

Other diseases of urinary system

455

1488

1.73

23.88

1.2

24.22

23.64

u/l

0.09

393

1286

ILD differential diagnosis

354

947

1.88

23.76

1.2

25.59

17.76

u/l

1.67

308

805

Other pulmonary diagnosis

354

948

1.88

23.69

1.3

1.2

25.55

17.59

u/l

1.69

306

807

Diseases of oral cavity, salivary glands and jaws

401

1149

1.80

23.56

1.2

26.20

24.43

u/l

0.22

345

980

Noninfectious colitis NAS

230

3.51

23.54

1.3

1.1

27.66

19.04

u/l

0.74

191

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

152

285

2.68

23.45

1.1

24.67

14.12

u/l

1.09

131

237

COPD differential diagnosis

353

948

1.87

23.43

1.2

25.57

17.78

u/l

1.65

307

806

Diseases of peritoneum

185

3.83

23.34

1.3

1.2

25.52

20.35

u/l

0.43

157

Follow-up examination after treatment for conditions other than malignant neoplasms

215

647

2.19

23.26

1.2

23.63

22.98

u/l

0.05

187

550

Disorders of thyroid, IBD co-morbidities

169

3.60

23.21

1.1

1.3

21.62

23.82

u/l

0.12

147

Cardiomyopathy

277

3.24

23.09

1.2

32.73

23.01

u/l

1.21

230

Mood disorders

458

1786

1.69

23.06

1.2

25.96

23.12

u/l

0.51

396

1540

Parodontitis

411

1758

1.73

23.01

1.3

1.2

24.97

24.78

u/l

0.02

357

1512

Parodontitis or operation codes

411

1758

1.73

22.94

1.3

1.2

24.97

24.78

u/l

0.02

357

1512

Arthropathies

389

1104

1.80

22.94

1.2

1.3

20.42

25.60

u/l

1.26

342

964

Mood [affective] disorders

456

1785

1.68

22.77

1.2

25.80

23.07

u/l

0.48

394

1539

Other systemic involvement of connective tissue (FG)

140

558

2.51

22.64

1.2

29.97

22.55

u/l

0.65

121

472

Cholecystectomy

337

1656

1.81

22.62

1.2

27.34

23.62

u/l

0.49

293

1416

All influenza

119

441

2.71

22.62

1.4

1.2

31.36

20.23

u/l

1.47

108

368

Other CVD (FINNGEN)

128

4.10

22.49

1.4

1.2

22.12

20.15

u/l

0.15

102

Bacterial intestinal infections, IBD co-morbidities

104

362

2.90

22.28

1.3

1.2

32.97

23.99

u/l

0.93

303

Dorsalgia

434

1373

1.72

22.23

1.2

25.82

23.60

u/l

0.37

377

1192

Abdominal and pelvic pain

438

1283

1.72

22.23

1.2

27.52

23.08

u/l

0.80

378

1097

Cystitis

388

1353

1.76

22.21

1.2

23.52

22.62

u/l

0.13

333

1165

Nephrotic syndrome

6.78

22.21

1.3

1.2

25.07

19.20

u/l

0.35

Enterocolitis due to Clostridium difficile

178

3.81

22.18

1.3

1.2

40.42

22.61

u/l

1.45

147

Chronic pancreatitis

211

3.55

22.09

1.3

1.2

39.94

22.86

u/l

1.21

177

Paralytic ileus and intestinal obstruction

129

504

2.58

22.07

1.4

1.2

42.96

23.94

u/l

1.75

112

417

Iron deficiency anaemia secondary to blood loss (chronic)

296

3.10

21.98

1.3

1.2

32.37

19.98

u/l

1.08

253

Injuries to the hip and thigh

218

970

2.07

21.97

1.3

1.2

29.11

25.42

u/l

0.45

188

819

Mood disorders, excluding more controls

425

1520

1.71

21.89

1.2

1.3

26.55

22.92

u/l

0.65

365

1319

Other diseases of pancreas

124

4.42

21.77

1.3

1.2

23.81

21.50

u/l

0.11

107

Chronic periodontitis, including avohilmo

405

1761

1.71

21.72

1.3

1.2

24.95

24.74

u/l

0.03

351

1516

Valvular heart disease excluding rheumatic fever

209

721

2.13

21.72

1.3

1.2

28.82

22.27

u/l

1.05

184

599

Gastro-oesophageal reflux disease

298

1432

1.85

21.67

1.3

1.2

24.47

25.16

u/l

0.08

256

1232

Asthma (diagnoses ohter than nonallergic)

380

1898

1.72

21.38

1.3

1.2

25.16

23.67

u/l

0.23

328

1639

Other functional intestinal disorders

203

928

2.09

21.32

1.3

1.2

31.50

21.68

u/l

1.46

181

795

Non-rheumatic valve diseases

207

716

2.12

21.32

1.3

1.2

29.04

22.31

u/l

1.08

182

594

Type 1 diabetes, strict (exclude DM2)

130

4.26

21.24

1.4

1.2

31.16

21.69

u/l

0.49

112

Type 1 diabetes, definitions combined

130

4.26

21.23

1.4

1.2

31.16

22.01

u/l

0.47

112

Other gastritis (incl. Duodenitis)

119

456

2.63

21.23

1.2

23.87

24.19

u/l

0.03

104

377

Benign neoplasms

409

1340

1.71

20.80

1.2

22.65

25.38

u/l

0.44

347

1169

Benign neoplasm: Colon, unspecified

113

424

2.67

20.80

1.2

27.50

22.43

u/l

0.42

357

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

292

1485

1.83

20.66

1.2

31.61

24.19

u/l

1.18

251

1260

Vitreous haemorrhage

179

3.68

20.47

1.4

1.2

28.32

19.58

u/l

1.01

151

Injuries to the abdomen, lower back, lumbar spine and pelvis

178

824

2.16

20.38

1.3

1.2

29.06

23.67

u/l

0.48

157

686

Symptoms and signs involving the circulatory and respiratory systems

428

1274

1.69

20.34

1.2

24.96

22.73

u/l

0.43

377

1096

Headache

260

1149

1.90

20.30

1.3

1.2

22.22

18.76

u/l

0.53

230

986

Disorder of lipoprotein metabolism, unspecified

228

3.32

20.29

1.3

1.2

32.64

25.31

u/l

0.41

186

Ulcerative proctitis

5.01

20.19

1.6

1.1

14.63

16.55

u/l

0.20

Symptoms and signs involving the digestive system and abdomen

430

1284

1.68

20.18

1.2

27.69

23.06

u/l

0.79

374

1098

Use of hypnotics and sedatives

462

1637

1.64

20.17

1.3

1.2

27.56

23.91

u/l

0.65

389

1424

Fracture of lumbar spine and pelvis

110

416

2.66

20.12

1.3

1.2

36.46

26.66

u/l

0.56

341

Depression medications

135

3.36

20.11

1.2

37.13

12.62

u/l

1.53

115

Dermatitis and eczema

466

1890

1.62

20.10

1.3

1.2

25.49

24.38

u/l

0.15

409

1632

Collagenous colitis

154

3.88

20.07

1.3

1.1

29.85

20.92

u/l

0.68

130

Psoriatic and enteropathic arthropathies

191

3.54

20.03

1.2

14.86

19.23

u/l

0.63

163

Cardiodefibrillation

168

770

2.19

20.03

1.2

1.3

25.66

27.04

u/l

0.20

145

644

Hyperlipidaemia, other/unspecified

174

764

2.17

19.99

1.2

29.27

24.74

u/l

0.42

150

643

Cellulitis

110

419

2.64

19.89

1.4

1.2

32.61

22.55

u/l

1.20

103

353

Total colectomy

5.54

19.83

1.7

1.2

29.06

17.67

u/l

0.54

Total colectomy operation

5.54

19.83

1.7

1.2

29.06

17.67

u/l

0.54

Parasetamol

330

936

1.80

19.80

1.3

1.2

27.08

21.22

u/l

0.81

286

820

Primary_lymphoid and hematopoietic malignant neoplasms

122

490

2.51

19.79

1.2

45.54

23.17

u/l

2.65

110

408

Peripheral arterial reconstruction

300

2.96

19.63

1.3

1.2

30.35

24.80

u/l

0.69

249

199

974

2.04

19.61

1.3

1.2

30.77

21.06

u/l

1.18

180

821

Other/unspecified seropositive rheumatoid arthritis

150

664

2.27

19.58

1.2

22.32

23.11

u/l

0.09

135

556

L04AC Interleukin inhibitors

5.44

19.51

1.2

1.1

22.13

14.95

u/l

0.49

Parodontitis and operation codes

379

1757

1.68

19.50

1.3

1.2

24.84

24.81

u/l

0.00

328

1512

Methotrexate

275

3.04

19.47

1.1

23.76

18.84

u/l

0.53

231

Anxiety (asthma-related co-morbidities)

254

1063

1.89

19.42

1.2

1.3

20.42

21.31

u/l

0.10

216

915

Seropositive rheumatoid arthritis, wide

152

680

2.25

19.35

1.2

22.17

23.48

u/l

0.16

137

570

Pain (limb, back, neck, head abdominally)

306

837

1.84

19.34

1.2

23.77

25.32

u/l

0.16

262

721

Other or unspecified ileus, impaction or obstruction

324

2.86

19.33

1.5

1.2

49.17

22.76

u/l

1.85

262

Other diseases of pleura

200

876

2.03

19.24

1.3

1.2

48.97

24.34

u/l

3.54

176

729

Obesity and other hyperalimentation

266

1441

1.83

19.22

1.2

1.3

20.19

22.65

u/l

0.59

227

1241

Obesity

265

1435

1.84

19.22

1.2

1.3

20.27

22.67

u/l

0.57

226

1235

Symptoms and signs involving cognition, perception, emotional state and behaviour

416

1783

1.64

19.07

1.2

25.45

24.88

u/l

0.07

350

1553

Hypokalaemia

188

3.49

19.03

1.2

1.1

27.21

22.69

u/l

0.30

154

Other antidepressants

442

1412

1.64

18.95

1.2

1.3

26.37

24.85

u/l

0.21

372

1235

Anxiety disorders, excluding more controls

361

1409

1.70

18.92

1.2

1.3

21.80

21.67

u/l

0.02

309

1217

Atrial fibrillation and flutter with reimbursement

133

347

2.47

18.91

1.2

24.86

20.48

u/l

0.62

115

283

Decubitus ulcer and pressure area

4.90

18.74

1.5

1.2

39.80

19.53

u/l

2.00

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

146

653

2.25

18.62

1.2

21.95

23.24

u/l

0.16

131

547

Other systemic involvement of connective tissue

144

641

2.26

18.57

1.3

1.2

29.80

21.60

u/l

0.79

125

538

Benign neoplasm of other and ill-defined parts of digestive system

102

388

2.65

18.56

1.3

1.2

26.18

21.33

u/l

0.49

326

Obesity, other/unspecified

158

731

2.17

18.52

1.2

18.99

20.95

u/l

0.33

141

621

Other CVD

338

2.77

18.46

1.4

1.2

23.15

26.44

u/l

0.30

281

Other disorders of urethra and urinary system

306

1308

1.76

18.39

1.2

26.82

22.82

u/l

0.65

263

1123

Enlarged lymph nodes

279

2.96

18.38

1.3

1.2

32.04

20.53

u/l

0.93

238

Other diseases of stomach and duodenum

107

4.36

18.29

1.2

1.1

33.51

19.80

u/l

0.90

Benzodiazepine use

425

1883

1.61

18.21

1.2

25.76

24.56

u/l

0.17

356

1640

Presence of cardiac and vascular implants and grafts

197

740

2.02

18.20

1.2

36.59

26.74

u/l

1.55

171

623

Other diseases of arteries and capillaries

157

3.67

17.99

1.3

1.2

46.15

16.18

u/l

1.55

136

Diabetic retinopathy, strict definition

104

353

2.61

17.85

1.4

1.2

30.81

31.71

u/l

0.07

307

Intestinal stricture

147

671

2.20

17.85

1.3

1.2

40.26

24.47

u/l

1.53

125

552

Symptoms and signs concerning food and fluid intake

144

3.78

17.80

1.2

25.89

23.69

u/l

0.11

120

Cerebrovascular diseases (FINNGEN)

143

450

2.28

17.68

1.3

1.2

26.02

21.06

u/l

0.50

124

374

Diseases of the musculoskeletal system and connective tissue

209

518

2.03

17.66

1.2

1.3

20.91

25.11

u/l

0.49

174

459

Acute pancreatitis

369

2.65

17.65

1.2

46.47

21.96

u/l

1.66

310

Heart failure and coronary heart disease

146

486

2.25

17.61

1.2

1.3

36.30

30.42

u/l

0.55

128

411

L02BA Anti-estrogens

106

422

2.54

17.61

1.2

17.94

20.23

u/l

0.15

355

486

1640

1.57

17.60

1.3

1.2

27.57

22.55

u/l

1.00

431

1408

Other diseases of hard tissues of teeth

261

1073

1.82

17.58

1.2

26.14

23.58

u/l

0.31

231

914

Viral and other specified intestinal infections

284

2.87

17.55

1.3

1.2

38.73

18.07

u/l

1.93

244

Hypo-osmolality and hyponatraemia

314

2.78

17.42

1.1

1.2

30.55

26.45

u/l

0.32

252

All anxiety disorders

256

1138

1.82

17.41

1.2

20.36

20.63

u/l

0.03

217

987

Other necrotizing vasculopathies

120

4.06

17.38

1.4

1.2

22.62

18.52

u/l

0.36

103

Diabetic retinopathy

174

523

2.11

17.28

1.4

1.2

28.86

31.17

u/l

0.25

151

459

Other disorders of glucose regulation and pancreatic internal secretion

121

4.01

17.16

1.4

1.1

39.85

15.96

u/l

1.62

103

Vascular disorders of the intestines

104

4.28

17.14

1.3

22.62

23.09

u/l

0.03

Other necrotizing vasculopathies (FG)

4.93

17.10

1.4

1.1

21.41

17.42

u/l

0.27

Diseases of the eye and adnexa

340

998

1.71

17.06

1.3

1.2

19.05

25.22

u/l

1.68

297

867

Gastroduodenal ulcer

117

495

2.37

16.91

1.2

30.32

28.48

u/l

0.12

100

413

Coagulation defects, purpura and other haemorrhagic conditions

372

2.60

16.86

1.3

1.2

28.71

24.14

u/l

0.42

312

Cough

186

911

1.97

16.66

1.2

21.31

21.27

u/l

0.00

165

770

Neurotic, stress-related and somatoform disorders

375

1652

1.62

16.45

1.2

21.86

23.36

u/l

0.23

322

1428

Anxiety disorders

379

1669

1.61

16.44

1.2

21.72

23.37

u/l

0.27

326

1442

Other external causes of accidental injury

353

1059

1.67

16.39

1.3

1.2

22.47

22.72

u/l

0.03

303

923

Immunodeficiencies

4.81

16.15

1.4

1.1

21.35

16.75

u/l

0.52

Hypothyroidism, strict autoimmune

258

957

1.79

16.14

1.2

24.08

24.09

u/l

0.00

225

799

Dermatitis

259

1486

1.75

16.10

1.3

1.2

25.12

23.42

u/l

0.21

221

1258

Invasive ventilation

114

4.00

16.02

1.2

43.10

19.48

u/l

1.15

Accidents

351

1059

1.66

15.97

1.3

1.2

24.33

22.72

u/l

0.19

300

923

Abnormalities of gait and mobility

221

3.06

15.94

1.2

32.72

21.45

u/l

0.68

189

Bronchitis

441

1872

1.55

15.86

1.3

1.2

28.22

23.34

u/l

0.91

392

1610

Disorders of lens

312

1170

1.69

15.75

1.3

1.2

26.98

23.80

u/l

0.53

283

990

Other disorders of white blood cells

4.48

15.67

1.1

1.2

47.56

16.24

u/l

1.32

Other respiratory diseases principally affecting the interstitium

328

2.64

15.63

1.1

1.2

41.43

26.06

u/l

1.16

271

Diabetic neuropathy

233

2.98

15.60

1.3

41.36

27.33

u/l

0.92

198

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

159

790

2.02

15.54

1.2

26.69

22.30

u/l

0.40

136

668

Vitamin B12 deficiency anaemia

174

3.30

15.41

1.3

1.1

25.49

21.64

u/l

0.28

147

Conduction disorders

120

439

2.28

15.40

1.2

28.73

22.65

u/l

0.88

112

356

Hypotension

280

2.77

15.35

1.4

1.2

24.88

24.04

u/l

0.06

232

Asthma, including avohilmo

482

1853

1.51

15.33

1.3

1.2

27.05

23.92

u/l

0.51

415

1610

Other and unspecified dermatitis

219

1216

1.81

15.28

1.3

1.2

24.94

22.71

u/l

0.27

189

1029

Benign neoplasm: Sigmoid colon

298

2.70

15.24

1.3

1.2

21.73

19.49

u/l

0.27

246

Chronic tubulo-interstitial nephritis

4.94

15.24

1.3

1.1

18.14

14.02

u/l

0.52

Abnormal results of function studies

137

3.61

15.18

1.3

1.1

25.24

15.03

u/l

1.65

117

Calcific aortic valvular stenosis, diagnosis (helper)

124

553

2.21

15.14

1.3

1.2

31.87

27.47

u/l

0.59

115

462

Operations 2 for CAVS

124

553

2.21

15.14

1.3

1.2

31.87

27.47

u/l

0.59

115

462

Complications of internal orthopaedic prosthetic devices, implants and grafts

109

472

2.32

15.11

1.3

1.2

27.20

25.04

u/l

0.21

390

Calcific aortic valvular stenosis, operated

124

554

2.20

15.08

1.3

1.2

31.87

27.45

u/l

0.59

115

463

Calcific aortic valvular stenosis

124

554

2.20

15.08

1.3

1.2

31.87

27.45

u/l

0.59

115

463

Other acute lower respiratory infections

215

1136

1.81

15.02

1.3

1.2

33.30

23.70

u/l

1.10

189

966

Depression or dysthymia

303

1006

1.69

15.02

1.2

1.3

27.36

24.44

u/l

0.38

253

876

Calcific aortic valvular stenosis, including rheumatic fever

124

555

2.20

14.98

1.3

1.2

31.87

28.06

u/l

0.48

115

463

Injuries to the head

445

1907

1.52

14.88

1.2

29.91

23.25

u/l

1.23

375

1663

Acute pancreatitis (for exclusion)

402

2.43

14.85

1.2

46.47

22.80

u/l

1.56

333

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

121

530

2.21

14.74

1.3

1.2

19.62

21.02

u/l

0.10

103

449

Other dorsopathies, not elsewhere classified

409

1384

1.56

14.68

1.2

24.12

23.68

u/l

0.06

354

1202

Hypoglycaemia, other or unspecified

100

4.04

14.51

1.3

1.1

44.32

15.60

u/l

1.63

Other anxiety disorders

183

861

1.89

14.49

1.2

20.58

19.08

u/l

0.15

153

749

Other joint disorders

337

1104

1.63

14.43

1.2

1.3

20.04

25.60

u/l

1.42

290

964

Syncope and collapse

172

798

1.92

14.18

1.2

40.52

20.68

u/l

2.60

147

672

Acute bronchitis

174

903

1.90

14.11

1.3

1.2

30.53

23.67

u/l

0.76

154

759

Falls/tendency to fall

442

1455

1.52

14.08

1.3

1.2

25.01

22.26

u/l

0.55

378

1263

Sequelae of external causes of morbidity and mortality

120

558

2.16

14.04

1.2

24.42

23.80

u/l

0.05

102

466

Hypertensive Heart Disease

331

2.41

14.04

1.2

1.3

36.68

23.64

u/l

1.89

276

Benign neoplasm: Stomach

165

3.24

13.94

1.3

1.1

34.35

17.31

u/l

1.33

139

Irritable bowel syndrome

121

567

2.14

13.88

1.2

19.73

20.17

u/l

0.04

104

481

Abnormal weight loss

141

3.44

13.84

1.2

24.21

17.39

u/l

1.01

120

Fracture of lower leg, including ankle

235

1367

1.72

13.80

1.2

26.65

23.96

u/l

0.33

210

1156

Other/unspecified dorsalgia

162

842

1.92

13.74

1.2

22.13

21.88

u/l

0.03

134

712

Colectomy operation

339

2.50

13.66

1.4

1.2

39.96

24.53

u/l

1.12

288

Myocardial infarction, without ST-elevation

162

780

1.92

13.62

1.2

1.3

33.11

27.82

u/l

0.54

141

646

Paroxysmal tachycardia

338

2.39

13.61

1.4

1.2

27.44

21.59

u/l

0.40

282

Cardiomyopathy (excluding other)

188

3.05

13.60

1.2

35.96

20.20

u/l

2.13

152

Chronic lower respiratory diseases

487

1788

1.48

13.57

1.3

1.2

29.58

23.03

u/l

1.28

423

1550

Mycoses

120

567

2.13

13.50

1.4

1.2

44.86

20.65

u/l

2.12

108

471

Symptoms and signs involving the skin and subcutaneous tissue

282

1730

1.63

13.47

1.2

25.35

23.60

u/l

0.20

248

1476

Benign neoplasm: Colon, unspecified

113

522

2.18

13.47

1.2

27.50

24.84

u/l

0.18

436

Overexertion and strenuous or repetitive movements

179

3.10

13.45

1.3

1.1

28.91

17.89

u/l

1.25

149

Cardiomyopathies, Primary/intrinsic

179

3.09

13.43

1.2

36.56

20.03

u/l

2.24

147

Malignant neoplasm of breast, HER-negative

112

516

2.18

13.42

1.3

1.2

19.57

23.04

u/l

0.28

433

All influenza (not pneumonia)

227

2.84

13.42

1.4

1.1

35.64

19.19

u/l

1.29

192

Open wound of lower leg

261

2.70

13.37

1.4

1.1

24.79

22.02

u/l

0.30

221

Valvular operations

217

2.88

13.33

1.4

1.2

40.56

22.11

u/l

1.18

180

Soft tissue disorders

406

1383

1.53

13.23

1.3

1.2

21.78

24.15

u/l

0.44

347

1198

Discitis, unspecified

8.05

13.22

1.3

43.00

21.00

u/l

0.92

Other pleural conditions

176

3.10

13.18

1.3

1.2

48.00

22.89

u/l

1.61

145

Spondylopathies (FG)

224

2.83

13.16

1.1

1.2

24.14

22.59

u/l

0.06

191

Amiodarone users

177

3.08

13.06

1.1

1.3

28.84

20.76

u/l

1.19

148

Exposure to other specified factors

285

1663

1.61

13.01

1.3

1.2

25.42

23.20

u/l

0.33

247

1429

Fracture of rib(s), sternum and thoracic spine

122

590

2.08

12.93

1.3

1.2

25.80

24.93

u/l

0.06

103

484

Asthma, hospital admissions , main diagnosis only

333

1930

1.55

12.76

1.3

1.2

26.92

23.31

u/l

0.51

293

1664

Diagnoses used for exclusion with ILD

117

560

2.10

12.75

1.2

25.93

23.71

u/l

0.22

105

459

Other cataract

195

848

1.79

12.65

1.3

1.2

23.90

23.95

u/l

0.01

172

706

Hypoparathyroidism

4.56

12.64

1.3

1.2

24.04

14.76

u/l

0.88

Other reaction to severe stress, and adjustment disorders

149

782

1.91

12.53

1.3

1.2

19.90

19.46

u/l

0.05

135

674

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

394

1710

1.50

12.51

1.3

1.2

26.75

24.99

u/l

0.29

341

1470

Seropositive rheumatoid arthritis, strict definition

336

2.43

12.47

1.2

17.59

22.49

u/l

0.65

285

Need for other prophylactic measures

3.94

12.28

1.1

1.2

11.66

15.14

u/l

0.71

Injuries to the thorax

177

988

1.80

12.25

1.2

25.93

26.04

u/l

0.01

152

833

External causes of morbidity and mortality

274

834

1.65

12.23

1.2

25.67

21.96

u/l

0.39

232

729

Benign neoplasm: Transverse colon

148

3.20

12.17

1.3

1.1

42.93

21.38

u/l

0.59

126

Acute upper respiratory infections of multiple and unspecified sites

290

1371

1.59

12.10

1.3

1.2

23.80

23.39

u/l

0.05

264

1163

Other arrhythmias

244

1131

1.66

12.08

1.2

23.11

21.33

u/l

0.25

214

955

Genitourinary diseases

216

618

1.76

12.08

1.2

24.20

22.65

u/l

0.13

188

528

Persons encountering health services for examination and investigation

249

742

1.69

12.07

1.2

24.54

24.06

u/l

0.04

214

633

Intestinal adhesions without obstruction

134

3.31

12.03

1.2

1.1

43.56

20.68

u/l

1.32

114

Recurrent or chronic depression

168

659

1.85

12.02

1.2

1.3

28.68

21.14

u/l

0.71

145

575

Weight loss

160

3.09

11.95

1.2

23.90

16.94

u/l

1.09

136

Hernia

378

1719

1.49

11.79

1.3

1.2

26.29

24.79

u/l

0.18

324

1482

Reactive arthropathies

131

3.31

11.75

1.3

1.1

19.26

25.83

u/l

0.39

109

Seronegative rheumatoid arthritis

216

2.75

11.73

1.2

1.1

25.43

19.75

u/l

0.63

179

Dorsopathies

405

1391

1.49

11.72

1.2

21.81

23.58

u/l

0.30

351

1209

Diseases of the respiratory system

267

817

1.64

11.71

1.2

26.89

18.06

u/l

1.49

237

692

Gastric ulcer

304

2.45

11.64

1.2

1.1

34.73

27.67

u/l

0.40

252

Other medical care

155

827

1.84

11.50

1.5

1.2

42.08

23.39

u/l

2.42

143

691

216

1189

1.67

11.47

1.2

1.3

33.28

25.49

u/l

1.07

184

1030

Other disorders of teeth and supporting structures

393

2.25

11.46

1.3

1.2

37.79

22.63

u/l

1.03

321

Dizziness and giddiness

300

1578

1.55

11.34

1.2

24.49

24.73

u/l

0.03

251

1366

Injuries to the knee and lower leg

467

1873

1.43

11.27

1.3

1.2

25.69

24.12

u/l

0.27

412

1614

In situ neoplasms

134

671

1.91

11.23

1.2

33.23

21.19

u/l

1.07

121

572

Other (not insulin) diabetes medications

380

1547

1.48

11.23

1.2

30.16

22.98

u/l

1.43

331

1324

Osteoporosis with pathological fracture (FG)

125

3.32

11.23

1.2

1.1

29.82

19.25

u/l

0.91

106

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

281

2.46

11.22

1.4

1.2

28.45

23.13

u/l

0.42

241

Alcohol use disorder, Swedish definition

205

1134

1.68

11.17

1.2

1.3

34.31

25.48

u/l

1.19

173

979

Other (seronegative) rheumatoid arthritis, wide

450

2.15

11.13

1.2

27.55

22.67

u/l

0.57

372

Cardiac arrest

3.93

11.12

1.3

1.2

46.18

21.98

u/l

0.89

Persons with potential health hazards related to communicable diseases

139

737

1.88

11.09

1.3

1.2

26.51

19.19

u/l

0.58

123

643

Psoriasis

128

667

1.93

11.08

1.2

1.3

22.82

22.34

u/l

0.04

114

559

Sequelae with surgical and medical care as external cause

412

2.20

11.07

1.3

1.2

23.62

25.34

u/l

0.14

347

Trigger finger

324

2.36

11.06

1.3

1.2

24.18

17.49

u/l

0.78

278

Any mental disorder

448

1558

1.44

11.04

1.2

25.72

23.62

u/l

0.35

381

1355

Exclusions for E4_PCOS_BROAD

324

2.36

11.03

1.3

1.2

27.38

22.58

u/l

0.42

277

Myocardial infarction

205

870

1.70

11.03

1.3

30.75

26.13

u/l

0.55

174

737

Sciatica+with lumbago

203

1152

1.68

10.99

1.3

1.2

28.32

23.28

u/l

0.66

171

988

Neurological diseases, wide definition

212

2.28

10.96

1.2

1.3

19.87

22.87

u/l

0.23

187

Personality disorders, excluding more controls

101

486

2.09

10.92

1.1

1.2

22.33

16.90

u/l

0.51

425

Other special examinations and investigations of persons without complaint or reported diagnosis

241

742

1.65

10.80

1.3

1.2

20.12

24.06

u/l

0.78

210

633

Benign neoplasm: Stomach

192

2.79

10.79

1.3

1.1

34.35

16.49

u/l

1.45

165

Parodontitis or/and operation codes

265

992

1.59

10.75

1.3

23.88

25.26

u/l

0.16

228

862

Opening and dilatation of root channel of tooth

3.57

10.75

1.2

46.55

15.52

u/l

1.11

Early onset COPD, excluding more controls

360

2.26

10.69

1.1

1.2

41.22

16.64

u/l

1.73

297

Misadventures to patients during surgical and medical care

269

2.47

10.62

1.3

1.2

50.54

17.84

u/l

2.28

232

Hard cardiovascular diseases

320

1359

1.51

10.59

1.2

27.67

24.79

u/l

0.39

275

1155

Oesophagitis

3.76

10.59

1.3

1.2

27.00

16.58

u/l

0.77

Obesity due to excess calories

175

1019

1.72

10.55

1.2

1.3

21.26

21.03

u/l

0.03

147

872

Senile cataract

270

1067

1.57

10.52

1.3

1.2

27.46

24.06

u/l

0.52

242

898

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

154

757

1.79

10.44

1.6

1.2

51.45

22.20

u/l

3.85

135

636

Papulosquamous disorders

166

956

1.74

10.42

1.2

22.46

22.30

u/l

0.02

147

801

Intestinal malabsorption

3.90

10.41

1.4

1.2

33.50

15.00

u/l

1.72

Benign neoplasm: Rectum, anus and anal canal

333

2.29

10.40

1.3

1.2

29.27

20.61

u/l

0.58

275

Spondylosis

216

1138

1.63

10.38

1.2

31.19

23.52

u/l

1.08

180

975

Diseases of pulp and periapical tissues, including avohilmo

424

1535

1.44

10.38

1.2

26.09

24.57

u/l

0.21

355

1332

ILD, hospital admissions

272

2.44

10.38

1.1

1.2

44.20

23.07

u/l

1.47

228

Dental pulpitis 4

425

1540

1.44

10.35

1.2

25.84

24.56

u/l

0.17

357

1336

Other interstitial pulmonary diseases

273

2.43

10.30

1.1

1.2

44.20

24.85

u/l

1.26

227

Interstitial lung disease

274

2.42

10.22

1.1

1.2

44.20

24.95

u/l

1.25

229

Interstitial lung disease endpoints

274

2.42

10.22

1.1

1.2

44.20

24.95

u/l

1.25

229

Dental pulpitis 1

424

1541

1.43

10.18

1.2

25.88

24.56

u/l

0.18

356

1337

Macular pucker

287

2.39

10.16

1.3

1.2

31.60

21.89

u/l

0.66

244

Other local infections of skin and subcutaneous tissue

165

2.87

10.15

1.4

1.1

32.77

18.99

u/l

1.00

138

Cyst of kidney

113

3.31

10.13

1.2

20.23

19.46

u/l

0.04

Retention of urine

119

523

1.93

10.11

1.3

33.69

26.98

u/l

0.71

107

440

Behavioural syndromes associated with physiological disturbances and physical factors

120

633

1.90

10.03

1.2

22.36

19.43

u/l

0.23

106

545

Chronic rhinitis, nasopharyngitis and pharyngitis

139

769

1.81

10.02

1.3

1.2

18.17

19.96

u/l

0.17

119

652

Psychiatric diseases

432

1522

1.42

10.00

1.2

25.51

23.66

u/l

0.29

369

1320

221

1237

1.60

9.99

1.2

1.3

32.84

25.27

u/l

1.06

188

1072

Other and unspecified local infections of skin and subcutaneous tissue

151

2.94

9.91

1.4

1.1

34.05

19.58

u/l

0.99

128

Benign neoplasm: Ascending colon

207

2.63

9.88

1.2

35.13

19.18

u/l

0.86

177

Lichen simplex chronicus and prurigo

110

3.31

9.85

1.3

1.1

14.97

19.42

u/l

0.35

Melanocytic naevi

106

540

1.97

9.85

1.3

1.2

23.48

21.00

u/l

0.22

459

Fall involving bed

4.96

9.81

1.1

1.2

51.44

16.97

u/l

0.75

Benign neoplasm: Sigmoid colon

368

2.19

9.78

1.3

1.2

21.73

21.74

u/l

0.00

315

Benign neoplasm: Rectum

299

2.32

9.72

1.3

1.2

25.07

19.46

u/l

0.40

248

Unspecified haematuria

154

754

1.76

9.72

1.2

38.04

24.73

u/l

1.80

134

632

Substance abuse, excluding more controls

200

1074

1.63

9.72

1.2

1.3

34.95

23.26

u/l

1.71

169

933

Symptoms and signs involving the urinary system

295

1523

1.50

9.70

1.3

1.2

29.17

24.19

u/l

0.69

252

1301

Abnormal findings on diagnostic imaging of lung

189

1119

1.65

9.69

1.2

31.55

24.58

u/l

0.72

161

952

Venous thromboembolism

218

1333

1.59

9.68

1.3

1.2

30.92

25.19

u/l

0.80

195

1128

Non-selective monoamine reuptake inhibitors

167

954

1.70

9.67

1.1

1.3

27.35

22.35

u/l

0.47

141

815

Dental caries, including avohilmo

309

1050

1.51

9.61

1.2

24.90

24.25

u/l

0.07

257

913

Dental caries 1

309

1050

1.51

9.60

1.2

24.90

24.25

u/l

0.07

257

913

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

417

2.10

9.58

1.9

1.2

47.97

21.13

u/l

2.57

350

Tubulo-interstitial nephritis, not specified as acute or chronic

102

3.36

9.58

1.3

1.2

40.39

17.72

u/l

1.00

Congenital malformations, deformations and chromosomal abnormalities

216

1304

1.59

9.55

1.3

1.2

19.61

21.44

u/l

0.30

186

1128

Duodenal ulcer

171

2.77

9.52

1.2

1.1

20.59

22.85

u/l

0.18

137

Candidiasis

247

2.44

9.49

1.4

1.2

49.49

18.74

u/l

2.09

212

Type 2 diabetes, definitions combined

359

1482

1.45

9.46

1.2

28.66

23.10

u/l

1.03

311

1265

Conjunctivitis

289

1692

1.49

9.43

1.2

18.99

21.89

u/l

0.42

256

1455

Fracture of shoulder and upper arm

147

843

1.75

9.40

1.3

1.2

33.08

22.70

u/l

1.41

125

710

Unspecified fall

187

1135

1.64

9.40

1.2

23.11

24.21

u/l

0.14

166

965

Other/unspecified rheumatoid arthritis

256

2.40

9.27

1.2

1.1

25.93

19.32

u/l

0.84

216

Factors influencing health status and contact with health services

112

283

1.99

9.27

1.2

1.1

20.04

22.20

u/l

0.23

240

ILD, hospital admissions 1, main diag only

250

2.42

9.26

1.1

1.2

46.62

22.19

u/l

1.62

209

Superficial injury of head

436

2.05

9.25

1.2

26.15

20.72

u/l

0.71

374

Myocardial infarction, strict

183

806

1.66

9.23

1.3

30.98

26.99

u/l

0.39

155

678

Urticaria and erythema

147

849

1.74

9.20

1.2

20.26

21.26

u/l

0.09

128

721

Selective serotonin reuptake inhibitors

383

1415

1.43

9.13

1.2

1.3

27.74

24.84

u/l

0.35

321

1238

Degeneration of macula and posterior pole

181

907

1.65

9.10

1.3

1.2

26.49

27.37

u/l

0.07

149

777

Intracranial trauma

217

1026

1.58

9.09

1.2

29.38

25.79

u/l

0.34

188

900

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

157

715

1.72

9.07

1.2

42.06

22.75

u/l

2.47

136

602

STROKE

224

990

1.57

9.02

1.2

26.19

22.55

u/l

0.44

193

834

Type 2 diabetes, strict (exclude DM1)

359

1498

1.43

8.99

1.2

28.64

23.08

u/l

1.03

311

1277

Disorders of conjunctiva

311

1791

1.46

8.98

1.2

19.06

22.69

u/l

0.61

276

1540

Nonorganic sleeping disorders, excluding more controls

329

2.20

8.98

1.2

21.40

17.26

u/l

0.23

286

Disorders of synovium and tendon

202

1145

1.59

8.94

1.3

1.2

21.40

22.83

u/l

0.18

180

979

Benign neoplasm: Adrenal gland

117

3.11

8.94

1.3

1.2

20.61

18.15

u/l

0.14

COPD (mode)

113

477

1.89

8.92

1.1

1.2

36.67

18.16

u/l

1.79

397

Persistent mood disorders

416

2.05

8.89

1.1

1.2

13.71

19.72

u/l

1.16

347

Thyrotoxicosis, other and/or unspecified

432

2.02

8.76

1.1

1.2

19.23

21.09

u/l

0.13

370

Non-allergic asthma (mode), excluding more controls

336

2.16

8.72

1.3

1.2

31.74

13.63

u/l

1.77

282

Nerve, nerve root and plexus disorders

403

1822

1.39

8.66

1.3

1.2

22.14

25.93

u/l

1.00

353

1568

Erosion of teeth, including avohilmo

297

2.22

8.65

1.3

17.19

22.71

u/l

0.88

257

Major coronary heart disease event excluding revascularizations

253

1155

1.52

8.63

1.2

28.46

26.46

u/l

0.24

219

981

Type 2 diabetes, definitions combined, including avohilmo

357

1488

1.42

8.60

1.2

27.95

22.91

u/l

0.93

307

1270

Thyrotoxicosis

109

589

1.86

8.56

1.1

1.2

21.76

22.00

u/l

0.02

501

Inflammatory diseases of the central nervous system

131

2.92

8.53

1.2

1.1

23.09

16.89

u/l

0.49

111

Convulsions, not elsewhere classified

371

2.08

8.50

1.1

1.2

32.41

19.51

u/l

1.01

309

Injuries to the ankle and foot

245

1486

1.50

8.46

1.4

1.2

27.01

21.71

u/l

0.96

214

1285

Major coronary heart disease event

274

1233

1.49

8.46

1.2

29.10

25.93

u/l

0.42

238

1040

Other intervertebral disc disorders

308

1300

1.45

8.37

1.2

25.75

24.20

u/l

0.18

259

1124

Ischaemic heart disease, wide definition

311

1346

1.45

8.37

1.2

27.64

23.75

u/l

0.65

270

1143

Other diseases of anus and rectum

113

622

1.82

8.35

1.4

1.2

30.79

21.87

u/l

0.92

521

Multiple myeloma, excluding all cancers (controls excluding all cancers)

4.01

8.34

1.4

1.1

47.13

18.36

u/l

1.57

Acute upper respiratory infections

400

1816

1.38

8.26

1.3

1.2

24.29

23.80

u/l

0.07

359

1554

Scar conditions and fibrosis of skin

3.85

8.25

1.2

20.37

13.96

u/l

0.26

Other arthrosis

195

882

1.59

8.20

1.2

1.3

27.10

26.12

u/l

0.09

174

756

Disorders of skin appendages

174

1084

1.61

8.19

1.3

1.2

19.53

20.90

u/l

0.19

150

924

Pacemaker

118

645

1.78

8.12

1.2

32.67

28.63

u/l

0.51

106

538

Glucagon-like peptide-1 (GLP-1) analogues

220

1186

1.53

8.10

1.2

32.24

23.52

u/l

1.39

185

1008

Dental caries 1 and operation codes

332

1191

1.43

8.10

1.2

26.33

25.25

u/l

0.12

276

1034

Benign neoplasm of other and unspecified endocrine glands

223

2.39

8.06

1.3

1.1

21.75

19.22

u/l

0.18

190

Pruritus

199

2.48

8.04

1.2

1.1

25.72

20.05

u/l

0.48

165

Phobic anxiety disorders

193

2.50

8.03

1.1

1.2

27.88

21.48

u/l

0.27

168

Pulmonary heart disease, diseases of pulmonary circulation

124

713

1.74

7.95

1.3

1.2

36.26

25.21

u/l

1.04

109

589

Urticaria

119

677

1.76

7.93

1.2

22.20

21.20

u/l

0.07

102

581

Benign neoplasm: Transverse colon

189

2.51

7.89

1.3

42.93

20.17

u/l

0.64

162

Missing teeth due to accident, extraction or parodontitis

201

2.45

7.88

1.3

48.95

22.43

u/l

1.12

169

Delirium, not induced by alcohol and other psychoactive substances

183

2.53

7.86

1.1

1.2

34.56

19.03

u/l

0.95

151

Chronic sinusitis

168

1049

1.61

7.86

1.4

1.2

24.20

21.44

u/l

0.23

151

885

Disorders of vitreous body and globe

204

1301

1.53

7.80

1.3

1.2

21.49

23.24

u/l

0.25

175

1097

Mental and behavioural disorders due to psychoactive substance use

207

1281

1.53

7.77

1.2

1.3

33.94

24.41

u/l

1.32

176

1108

Disorders of vitreous body

200

1277

1.54

7.75

1.3

1.2

21.60

23.25

u/l

0.23

173

1077

Disorders of adult personality and behaviour

106

587

1.81

7.74

1.2

22.47

19.50

u/l

0.25

506

Sleep disorders (combined)

376

1791

1.38

7.74

1.2

21.82

24.94

u/l

0.68

326

1544

Hypothyroidism, other/unspecified

336

1584

1.40

7.69

1.2

25.98

24.30

u/l

0.20

292

1360

Functional dyspepsia

104

574

1.82

7.68

1.2

23.66

24.06

u/l

0.02

484

Dental caries 3

318

1142

1.43

7.60

1.2

26.91

24.35

u/l

0.31

262

997

Hypothyreosis and Thyroxine purchase for inclusion criteria

350

1665

1.39

7.59

1.2

25.60

23.79

u/l

0.23

305

1427

Substance abuse

200

1252

1.53

7.57

1.2

1.3

34.95

24.16

u/l

1.52

169

1080

malignant neoplasm of male genital organs

124

449

1.76

7.57

1.7

1.2

38.66

28.92

u/l

0.75

110

381

Arterial embolism and thrombosis

3.18

7.53

1.2

24.04

24.66

u/l

0.02

Disorders of the thyroid gland

354

1673

1.38

7.52

1.2

25.58

24.97

u/l

0.07

302

1437

Visual disturbances and blindness

189

1227

1.54

7.52

1.2

22.24

24.31

u/l

0.25

165

1039

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

207

1347

1.51

7.50

1.2

18.13

21.88

u/l

0.49

184

1158

Acute sinusitis

186

1121

1.55

7.46

1.3

1.2

25.72

21.69

u/l

0.48

173

957

Nonorganic sleeping disorders

355

2.04

7.45

1.2

21.40

19.81

u/l

0.08

305

Personality disorders

101

559

1.81

7.41

1.1

1.2

22.33

19.31

u/l

0.24

479

Allergic conjunctivitis

214

1408

1.50

7.41

1.2

18.34

21.97

u/l

0.48

188

1214

Other specified/unspecified bacterial intestinal infections

109

2.96

7.39

1.2

19.16

16.99

u/l

0.22

Multiple myeloma and malignant plasma cell neoplasms

3.77

7.36

1.4

1.1

45.09

18.20

u/l

1.36

Spinal stenosis

197

1009

1.53

7.34

1.2

28.52

23.75

u/l

0.59

165

857

Allergic asthma (mode), excluding more controls

404

1.95

7.32

1.3

1.2

26.61

13.31

u/l

1.20

339

Sleep disorders

427

1.93

7.28

1.2

20.99

19.69

u/l

0.07

366

Panic disorder

240

2.26

7.28

1.3

1.2

15.33

19.63

u/l

0.38

208

Open wound of head

177

1126

1.55

7.20

1.2

30.31

24.35

u/l

0.76

150

966

Ankylosing spondylitis, ICD10

150

2.62

7.19

1.1

25.03

17.18

u/l

0.28

126

Ischemic heart diseases

306

1362

1.41

7.17

1.2

27.85

24.04

u/l

0.62

267

1157

Disorders of sclera, cornea, iris and ciliary body

197

1305

1.51

7.16

1.3

1.2

27.26

23.39

u/l

0.42

182

1103

Non-allergic asthma (mode)

364

1.99

7.14

1.3

1.2

31.74

15.91

u/l

1.44

305

Calculus of kidney and ureter

108

617

1.76

7.14

1.3

21.38

25.38

u/l

0.47

518

Asthma/COPD (KELA code 203)

347

1783

1.37

7.13

1.3

1.2

32.15

23.09

u/l

1.51

299

1545

Concussion

174

967

1.56

7.13

1.2

31.02

26.45

u/l

0.36

150

846

Malignant neoplasm of prostate

120

436

1.74

7.12

1.7

1.2

36.99

28.94

u/l

0.60

106

369

Subjective visual disturbances

545

1.81

7.11

1.2

18.64

23.41

u/l

0.73

456

Lung cancer and mesothelioma

279

2.06

7.00

1.2

34.05

19.83

u/l

1.08

233

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

164

2.52

7.00

1.2

20.08

19.80

u/l

0.02

139

Disorders of continuity of bone

177

2.45

6.91

1.2

1.1

21.18

22.71

u/l

0.08

152

Dental caries 3 and operation codes

341

1267

1.38

6.91

1.2

27.10

24.75

u/l

0.30

280

1103

Dipeptidyl peptidase 4 (DPP-4) inhibitors

221

2.28

6.86

1.2

35.11

19.83

u/l

0.92

191

Dental pulpitis 4, only avohilmo

414

1619

1.34

6.80

1.2

25.68

25.20

u/l

0.06

345

1412

Visual disturbances

174

1137

1.53

6.78

1.2

22.35

22.48

u/l

0.01

150

965

Polymyalgia rheumatica

235

2.23

6.77

1.1

1.2

22.85

20.80

u/l

0.17

201

Benign neoplasm: Adrenal gland

138

2.63

6.71

1.3

1.2

20.61

16.69

u/l

0.25

118

Psoriatic arthropathies

174

2.43

6.67

1.2

14.06

18.30

u/l

0.49

148

Coronary atherosclerosis

259

1170

1.43

6.66

1.2

30.51

25.01

u/l

0.77

220

987

Transport accidents

149

834

1.59

6.63

1.3

1.2

24.43

21.84

u/l

0.17

122

721

Thyroiditis, ILD-related definition

193

2.34

6.62

1.2

15.40

17.50

u/l

0.30

166

Cerebral palsy and other paralytic syndromes

200

2.31

6.57

1.5

1.1

22.00

20.41

u/l

0.10

169

Other embolism and thrombosis

245

2.17

6.54

1.2

25.91

19.63

u/l

0.61

203

Psoriasis vulgaris

394

1.91

6.54

1.1

1.2

26.02

23.41

u/l

0.17

331

Hydronephrosis

170

2.42

6.50

1.3

1.2

18.77

20.52

u/l

0.13

140

Dislocation, sprain and strain of joint and ligaments of hip

3.68

6.49

1.4

1.2

23.27

17.72

u/l

0.25

Coxarthrosis [arthrosis of hip](FG)

196

950

1.50

6.47

1.2

22.99

24.22

u/l

0.18

167

813

Other symptoms and signs involving cognitive functions and awareness

163

994

1.54

6.46

1.2

24.38

25.23

u/l

0.08

134

855

Infection due to other mycobacteria

6.21

6.45

1.8

1.2

53.09

14.23

u/l

0.76

Carbimazole or st.post thyroidectomy, condition for graves disease

475

1.82

6.43

1.1

1.2

20.11

19.86

u/l

0.01

406

Retinal detachments and breaks

130

805

1.62

6.41

1.2

1.3

23.94

24.35

u/l

0.04

106

686

Benign neoplasm: Ascending colon

254

2.14

6.40

1.2

35.13

23.23

u/l

0.56

220

Other viral diseases

562

1.74

6.38

1.2

30.52

18.80

u/l

1.24

484

Dental pulpitis 2

262

942

1.43

6.38

1.2

27.49

24.96

u/l

0.29

222

815

Mental and behavioural disorders due to opioids

4.08

6.36

1.2

35.53

30.29

u/l

0.08

Procreative management

121

618

1.66

6.35

1.3

1.2

24.88

19.42

u/l

0.42

109

538

Calcinosis cutis

+∞

6.35

1.8

0.0

16.33

—

u/l

—

Other disorders of bone

384

1.91

6.35

1.2

1.1

26.70

20.17

u/l

0.61

331

Memory loss

166

2.43

6.35

1.2

32.13

19.52

u/l

0.75

139

Retinal vascular disorders

216

2.23

6.34

1.1

1.2

30.50

26.06

u/l

0.27

185

Spondylopathies in diseases classified elsewhere

6.81

6.34

1.4

1.3

24.40

21.10

u/l

—

Obesity related asthma

126

777

1.63

6.33

1.3

1.2

23.64

20.59

u/l

0.46

108

656

Monoamine oxidase A inhibitors

262

2.11

6.31

1.2

29.26

18.97

u/l

0.46

224

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

165

736

1.55

6.31

1.2

27.11

22.67

u/l

0.58

140

617

Urolithiasis

112

671

1.67

6.29

1.3

20.84

25.34

u/l

0.59

567

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

278

1.86

6.29

1.9

1.2

32.15

26.24

u/l

0.29

234

Abnormalities of heart beat

126

771

1.62

6.29

1.2

1.3

24.30

20.66

u/l

0.42

111

649

Postmenopausal osteoporosis with pathological fracture

114

2.75

6.28

1.2

21.48

16.96

u/l

0.36

Benign neoplasm: Rectum

358

1.94

6.27

1.3

1.2

25.07

22.43

u/l

0.15

301

Substance use, excluding alcohol

358

1.93

6.26

1.2

33.07

20.80

u/l

0.76

307

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

356

1.87

6.25

1.2

40.21

22.99

u/l

1.14

297

Exclusions for E4_PCOS_CONSORTIUM

278

1250

1.40

6.25

1.3

1.2

23.38

21.67

u/l

0.24

241

1074

Benign neoplasm of other and unspecified endocrine glands

250

2.13

6.24

1.3

1.2

21.75

19.45

u/l

0.15

214

Allergic asthma (mode)

428

1.84

6.22

1.3

1.2

26.61

14.28

u/l

1.07

360

Cholecystitis

244

2.14

6.20

1.5

1.2

39.63

22.87

u/l

0.83

206

Dental pulpitis 2, only avohilmo

266

964

1.41

6.19

1.2

27.36

24.83

u/l

0.29

222

836

Ankylosing spondylitis

162

2.42

6.18

1.1

1.2

25.03

19.15

u/l

0.20

127

Dysphagia

506

1.76

6.06

1.4

1.2

27.03

21.26

u/l

0.65

414

Retinal vascular occlusion

214

2.21

6.05

1.1

1.2

29.00

24.94

u/l

0.25

183

Dental pulpitis 1, only avohilmo

410

1632

1.31

6.03

1.2

23.89

25.65

u/l

0.27

342

1424

Thyrotoxicosis with toxic multinodular goitre

117

2.67

5.99

1.2

33.96

16.73

u/l

0.60

100

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

289

1.82

5.95

1.8

1.2

36.09

26.01

u/l

0.53

240

Dental caries 1, only avohilmo

304

1135

1.37

5.94

1.2

24.95

25.56

u/l

0.07

251

994

Degenerative macular diseases

216

2.19

5.93

1.2

18.58

22.21

u/l

0.37

189

Fall on same level involving ice and snow

205

1427

1.44

5.90

1.2

29.66

22.40

u/l

1.17

181

1213

Other and unspecified urticaria

402

1.85

5.87

1.2

25.02

21.06

u/l

0.22

344

Mental and behavioural disorders due to alcohol

167

1088

1.50

5.85

1.1

1.3

34.98

24.81

u/l

1.15

142

939

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

160

725

1.53

5.81

1.3

1.2

27.72

22.90

u/l

0.63

137

608

Benign neoplasm: Rectum, anus and anal canal

418

1.83

5.80

1.2

29.27

21.65

u/l

0.48

351

Unspecified acute lower respiratory infection

251

2.08

5.79

1.2

45.11

19.08

u/l

1.00

206

Abscess of anal and rectal regions

125

2.57

5.78

1.2

1.1

16.42

18.09

u/l

0.10

101

Stroke, excluding SAH

217

1130

1.43

5.77

1.2

30.05

25.76

u/l

0.44

185

966

Fracture of skull and facial bones

397

1.84

5.77

1.2

36.39

19.60

u/l

0.75

342

Arthrosis

246

960

1.41

5.77

1.2

1.3

20.82

27.46

u/l

1.17

208

828

Biguanides

354

1649

1.32

5.73

1.2

31.90

24.25

u/l

1.45

309

1412

Generalized anxiety disorder

259

2.05

5.72

1.2

19.13

19.49

u/l

0.01

226

Soft tissue disorders related to use, overuse and pressure

103

621

1.66

5.70

1.2

19.41

23.13

u/l

0.51

525

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

184

854

1.47

5.68

1.4

1.2

24.04

21.59

u/l

0.34

157

717

Coxarthrosis

177

810

1.48

5.66

1.2

1.3

22.52

25.99

u/l

0.65

149

695

Aortic aneurysm

393

1.83

5.63

1.2

1.3

32.88

25.95

u/l

0.58

329

Anaemia in chronic diseases classified elsewhere

4.30

5.57

1.4

1.2

32.14

14.15

u/l

1.26

Retinal detachment with retinal break

235

2.10

5.57

1.2

21.78

23.55

u/l

0.15

200

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

164

2.33

5.57

1.2

38.00

20.45

u/l

1.11

136

Polyuria

424

1.80

5.55

1.4

1.2

36.61

21.56

u/l

0.80

355

Injury, poisoning and certain other consequences of external causes

202

696

1.46

5.54

1.2

28.00

21.31

u/l

0.60

170

614

Diseases of salivary glands

375

1.85

5.49

1.2

28.49

23.04

u/l

0.28

310

Pulmonary embolism

106

651

1.63

5.47

1.3

1.2

35.54

25.46

u/l

0.78

533

Melanocytic naevi

106

652

1.63

5.45

1.3

1.2

23.48

20.79

u/l

0.24

556

Fissure and fistula of anal and rectal regions

501

1.72

5.42

1.1

1.2

18.16

20.79

u/l

0.33

424

Use of pramipexole

517

1.71

5.40

1.3

1.2

20.01

24.19

u/l

0.43

433

Mental and behavioural disorders due to alcohol, excluding acute intoxication

144

953

1.51

5.36

1.2

1.3

38.24

24.58

u/l

1.43

120

817

Fenamates

235

1.90

5.35

1.1

1.2

16.96

23.37

u/l

1.29

213

Deforming dorsopathies

106

656

1.62

5.33

1.3

1.2

23.43

21.96

u/l

0.15

557

In situ neoplasms

134

876

1.53

5.32

1.2

33.23

23.26

u/l

0.81

121

736

Dental operations

242

891

1.40

5.31

1.2

31.35

24.88

u/l

0.80

203

765

Cystic fibrosis with pulmonary manifestations

+∞

5.29

2.6

0.0

40.40

—

u/l

—

Pulmonary heart disease

106

658

1.62

5.26

1.3

1.2

35.54

25.33

u/l

0.80

537

Special screening examination for infectious and parasitic diseases

280

1.85

5.25

1.2

19.48

22.12

u/l

0.15

240

Other disorders of veins

151

1016

1.49

5.22

1.2

24.75

21.94

u/l

0.46

126

864

Neurological diseases

318

1203

1.33

5.21

1.3

1.2

23.15

25.31

u/l

0.28

265

1059

Vitamin deficiency

2.90

5.20

1.5

1.2

17.65

17.39

u/l

0.02

Vitamin deficiency, wide

2.90

5.20

1.5

1.1

17.65

17.39

u/l

0.02

Other renal tubulo-interstitial diseases

4.05

5.18

1.3

1.1

22.21

14.79

u/l

0.46

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

3.24

5.17

1.3

1.1

51.93

18.24

u/l

0.53

Other diseases of jaws

103

2.64

5.14

1.2

6.80

26.68

u/l

2.87

Episodal and paroxysmal disorders

411

1644

1.28

5.13

1.2

25.51

24.99

u/l

0.06

344

1433

Intracranial injury

187

1271

1.42

5.12

1.2

30.73

22.46

u/l

0.92

160

1100

Sequelae of injuries of lower limb

177

2.22

5.12

1.2

25.94

19.84

u/l

0.30

148

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

3.80

5.10

1.4

1.2

44.93

22.79

u/l

0.72

Multiple myeloma

3.80

5.10

1.4

1.2

44.93

22.79

u/l

0.72

Coronary artery bypass grafting

401

1.69

5.09

1.3

1.4

36.44

29.72

u/l

0.34

336

Shoulder lesions

269

1219

1.35

5.08

1.2

23.17

25.64

u/l

0.40

228

1043

Cerebrovascular diseases

266

1414

1.35

5.07

1.3

1.2

29.08

25.32

u/l

0.45

225

1209

Leiomyoma of uterus

170

652

1.47

5.07

1.3

1.2

19.09

20.97

u/l

0.24

146

555

Injuries to the shoulder and upper arm

292

1848

1.33

5.07

1.2

30.27

24.05

u/l

0.97

254

1586

DVT of lower extremities and pulmonary embolism

151

1020

1.48

5.07

1.3

1.2

30.78

25.14

u/l

0.57

140

851

Emergency coronary revascularization (for ACS)

180

899

1.44

5.05

1.2

1.3

33.02

28.58

u/l

0.41

155

756

COPD, hospital admissions 3, with asthma pneumonia sepsis

465

1.67

5.03

1.2

39.25

28.74

u/l

0.63

392

Melanocytic naevi of trunk

172

2.22

5.02

1.2

1.1

31.97

22.43

u/l

0.35

149

Arthropathic psoriasis

225

2.05

5.01

1.2

16.22

22.10

u/l

0.58

189

Acquired haemolytic anaemia

3.94

5.00

1.2

32.86

15.03

u/l

1.50

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

231

2.01

4.96

1.1

1.2

29.05

21.04

u/l

0.49

192

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

161

753

1.47

4.95

1.4

1.2

26.47

22.61

u/l

0.48

136

630

Dental caries 3, only avohilmo

315

1220

1.32

4.94

1.2

25.32

25.20

u/l

0.01

259

1071

Fracture of forearm

202

1358

1.40

4.93

1.2

16.93

22.48

u/l

2.09

169

1158

Diffuse large B-cell lymphoma, helper endpoint

3.24

4.90

1.2

1.1

31.50

19.02

u/l

0.53

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

3.24

4.90

1.2

1.1

31.50

19.02

u/l

0.53

Radiculopathy

361

1.81

4.88

1.1

1.2

21.23

22.31

u/l

0.10

293

Malignant melanoma, excluding all cancers (controls excluding all cancers)

283

1.92

4.85

1.3

1.2

39.51

19.76

u/l

1.17

233

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

143

2.32

4.84

1.2

41.93

21.57

u/l

1.12

122

Insomnia

312

1.87

4.82

1.2

26.41

20.75

u/l

0.26

267

Coronary revascularization (ANGIO or CABG)

157

749

1.47

4.79

1.3

31.06

26.98

u/l

0.33

134

627

Other pulmonary heart/vessel disease

2.90

4.77

1.3

1.2

40.81

18.63

u/l

1.46

Pneumonia derived septicemia

3.43

4.75

1.6

1.2

35.44

19.54

u/l

0.57

Fibroblastic disorders

514

1.66

4.73

1.3

30.19

24.04

u/l

0.49

434

Specific personality disorders

462

1.69

4.69

1.1

1.2

22.05

19.66

u/l

0.18

395

Lumbar disc prolapse

216

1253

1.37

4.68

1.2

27.29

23.88

u/l

0.40

180

1080

Emotionally unstable personality disorder

184

2.13

4.68

1.1

1.2

17.91

21.59

u/l

0.25

157

Myalgia

493

1.67

4.67

1.3

1.2

24.82

22.27

u/l

0.16

416

Injuries to the elbow and forearm

246

1662

1.34

4.66

1.2

17.00

23.42

u/l

2.90

206

1429

Macular hole

103

2.55

4.63

1.3

1.2

13.43

17.90

u/l

0.64

Multiple myeloma and malignant plasma cell neoplasms

2.77

4.62

1.4

1.2

45.09

20.99

u/l

1.16

Secondary right heart disease

2.99

4.56

1.3

1.2

37.07

19.07

u/l

1.30

Cytomegalovirus infection, IBD co-morbidity

3.87

4.55

1.1

40.69

13.22

u/l

1.50

Maternal care for other conditions predominantly related to pregnancy

401

1.73

4.53

1.2

17.12

19.55

u/l

0.27

345

Abnormal findings on diagnostic imaging of other body structures

255

1.93

4.52

1.2

1.1

33.00

20.24

u/l

0.70

217

Haemolytic anaemias

3.18

4.49

1.2

41.00

18.63

u/l

0.91

Trochanteric bursitis

313

1.83

4.47

1.1

1.2

21.81

20.14

u/l

0.15

267

Excessive attrition of teeth

118

415

1.55

4.46

1.3

22.87

25.16

u/l

0.16

105

352

Pain in thoracic spine

314

1.82

4.43

1.2

24.06

21.06

u/l

0.19

262

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

302

1.77

4.42

1.2

29.89

22.01

u/l

0.63

256

COPD, hospital admission 2, with asthma infections

107

591

1.55

4.41

1.1

1.2

37.31

28.88

u/l

0.55

498

Atopic dermatitis

177

1080

1.40

4.41

1.3

1.2

24.56

21.17

u/l

0.26

157

936

Other and unspecified vascular occlusions

156

2.19

4.39

1.1

1.3

31.59

20.15

u/l

0.76

137

Other headache syndromes

151

1055

1.43

4.39

1.3

20.91

22.28

u/l

0.10

128

904

Phlebitis and thrombophlebitis (not including DVT)

502

1.64

4.38

1.2

31.53

22.98

u/l

0.96

417

Disturbances of skin sensation

596

1.58

4.36

1.3

1.2

21.80

20.89

u/l

0.06

510

Symptoms and signs involving speech and voice

119

798

1.50

4.29

1.3

1.2

26.13

22.83

u/l

0.32

106

672

Single spontaneous delivery

693

0.62

4.28

1.2

33.93

22.36

u/l

0.46

608

Gonarthrosis [arthrosis of knee](FG)

254

1129

1.33

4.25

1.2

21.63

25.93

u/l

0.77

208

971

Hypopituitarism

102

2.46

4.21

1.3

1.1

43.30

19.66

u/l

1.07

Voice disturbances

641

1.55

4.21

1.3

1.2

26.78

23.03

u/l

0.33

535

Viral infections characterized by skin and mucous membrane lesions

138

956

1.45

4.20

1.3

1.2

22.31

24.09

u/l

0.17

127

806

Diseases of the myoneural junction and muscle

220

1.96

4.19

1.2

1.1

34.94

19.88

u/l

1.57

185

Early onset COPD

501

1.62

4.18

1.1

1.3

41.22

23.16

u/l

1.07

421

Other enthesopathy of foot (+metatarsalgia)

207

1.99

4.15

1.3

1.2

25.74

20.09

u/l

0.34

182

Stroke, including SAH

220

1215

1.34

4.15

1.3

1.2

29.98

25.35

u/l

0.50

189

1040

Ingrowing nail

2.60

4.14

1.3

1.1

20.86

14.07

u/l

0.72

Abrasion of teeth

376

1.63

4.14

1.2

1.3

19.54

25.12

u/l

0.63

319

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

541

1.59

4.14

1.2

30.91

16.91

u/l

1.02

468

Alcohol use disorder, ICD-based

129

886

1.46

4.13

1.2

35.86

25.57

u/l

1.00

106

755

Other enthesopathies

107

708

1.51

4.12

1.3

1.2

35.35

22.63

u/l

0.92

601

Otitis externa

449

1.65

4.12

1.4

1.2

28.35

22.35

u/l

0.35

382

Ischaemic Stroke, excluding all haemorrhages

192

1063

1.37

4.11

1.2

31.02

25.95

u/l

0.48

162

906

Benign neoplasm of eye and adnexa

161

2.12

4.09

1.1

1.2

18.66

18.24

u/l

0.02

138

Localized swelling, mass and lump of skin and subcutaneous tissue

110

734

1.50

4.08

1.2

29.26

21.70

u/l

0.53

612

Metatarsalgia

188

2.03

4.08

1.3

1.2

24.10

15.38

u/l

0.68

168

Unstable angina pectoris

125

706

1.47

4.07

1.2

1.3

29.35

28.04

u/l

0.12

109

587

Sulfonylureas

126

686

1.47

4.06

1.3

39.20

25.01

u/l

1.98

113

573

Other diseases of lip and oral mucosa

316

1.78

4.05

1.4

1.2

28.22

22.60

u/l

0.25

261

Psoriatic arthropathies, ICD10

216

1.95

4.05

1.2

14.06

21.36

u/l

0.93

182

Follicular cysts of skin and subcutaneous tissue

368

1.72

4.05

1.3

1.2

19.23

22.71

u/l

0.41

311

Palmar fascial fibromatosis [Dupuytren]

287

1.82

4.05

1.3

30.52

26.43

u/l

0.22

237

Other disorders of the musculoskeletal system and connective tissue

303

1.79

3.99

1.2

21.65

20.87

u/l

0.07

258

Benign neoplasm: Duodenum

3.97

3.98

1.3

1.1

23.64

21.43

u/l

0.09

Keratitis

116

787

1.48

3.98

1.4

1.2

30.54

22.51

u/l

0.63

109

661

Dental operations, only avohilmo

251

976

1.32

3.97

1.2

33.95

25.41

u/l

0.95

213

845

Faecal incontinence

197

1.99

3.97

1.4

1.2

22.28

20.60

u/l

0.10

162

Hernia of abdominal wall

146

1035

1.41

3.96

1.3

1.2

35.35

23.88

u/l

1.10

131

868

Family history of malignant neoplasm

197

1.99

3.96

1.4

1.1

17.15

20.90

u/l

0.24

168

Other and unspecified mood [affective] disorders

2.54

3.96

1.1

34.77

25.72

u/l

0.17

Somatoform disorder

341

1.74

3.94

1.3

1.2

32.02

18.73

u/l

0.68

293

Hyperaldosteronism

3.16

3.94

1.3

1.1

21.40

16.10

u/l

—

Traumatic subdural haemorrhage

208

1.94

3.91

1.1

1.2

21.72

25.95

u/l

0.39

177

Cytomegaloviral disease

3.46

3.91

1.1

1.2

40.69

13.63

u/l

1.48

Vocal cord dysfunction

164

2.04

3.91

1.3

1.2

15.53

16.52

u/l

0.10

136

Other surgical follow-up care

3.45

3.91

1.3

1.2

37.46

11.78

u/l

0.54

Benign neoplasm: Small intestine

2.90

3.90

1.2

1.1

19.29

18.04

u/l

0.08

COPD

149

874

1.41

3.87

1.2

34.08

24.83

u/l

0.91

125

740

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.79

3.85

1.3

1.1

24.72

24.16

u/l

0.01

Myeloproliferative diseases

152

2.12

3.84

1.3

1.2

20.70

16.60

u/l

0.48

131

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

576

1.55

3.83

1.2

1.3

26.94

18.20

u/l

0.99

485

Recurring oral aphthae, including avohilmo

271

1.82

3.81

1.2

42.41

22.46

u/l

0.90

234

Symptoms and signs involving the nervous and musculoskeletal systems

193

1444

1.34

3.77

1.2

30.12

22.85

u/l

0.71

153

1240

Delivery

693

0.65

3.76

1.2

32.86

22.36

u/l

0.43

608

Other disorders of skin and subcutaneous tissue, not elsewhere classified

265

1.82

3.76

1.2

25.19

20.38

u/l

0.34

223

Other infective otitis externa

102

2.37

3.74

1.3

1.2

15.00

16.03

u/l

0.07

Other diseases of gallbladder

2.58

3.72

1.2

64.60

15.30

u/l

0.77

Other skin changes

348

1.70

3.70

1.2

26.31

20.75

u/l

0.56

295

Angina pectoris

207

1052

1.33

3.69

1.2

27.47

24.65

u/l

0.30

186

892

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

245

1.84

3.69

1.3

1.2

47.82

19.03

u/l

1.49

211

Restless leg syndrome

238

1.86

3.68

1.1

1.2

13.42

21.76

u/l

1.33

206

Gonarthrosis

214

925

1.33

3.68

1.2

1.3

21.38

27.16

u/l

1.06

175

797

Other psoriatic arthropathies

203

1.93

3.67

1.2

14.55

22.05

u/l

0.86

169

Conjunctivitis (acute, non atopic)

589

1.53

3.64

1.2

19.46

20.48

u/l

0.06

496

Corneal scars and opacities

3.28

3.63

1.2

1.1

31.31

15.85

u/l

0.76

Thyrotoxicosis with diffuse goitre

305

1.74

3.63

1.1

1.2

18.34

18.62

u/l

0.02

266

Malignant neoplasm of digestive organs

123

847

1.43

3.62

1.2

1.3

46.07

26.01

u/l

1.85

104

711

Appendectomy

215

1583

1.31

3.62

1.3

1.2

33.47

22.27

u/l

1.46

190

1362

Other follicular disorders

110

2.28

3.61

1.2

32.83

23.06

u/l

0.21

Superficial injury of abdomen, lower back and pelvis

254

1.82

3.61

1.3

1.2

17.00

20.75

u/l

0.50

210

Unspecified lump in breast

412

1.63

3.60

1.3

1.2

20.05

21.22

u/l

0.06

352

Poisoning by drugs, medicaments and biological substances

490

1.58

3.59

1.2

29.06

19.61

u/l

0.67

420

Seborrhoeic dermatitis

157

2.05

3.55

1.6

1.1

18.04

17.32

u/l

0.03

131

Bipolar affective disorders

360

1.67

3.54

1.2

23.64

17.64

u/l

0.42

307

Sequelae of cerebrovascular disease

111

670

1.46

3.54

1.2

31.13

26.53

u/l

0.37

562

Disorders of eyelid, lacrimal system and orbit

292

1821

1.26

3.52

1.2

22.19

25.29

u/l

0.51

246

1571

Follow-up examination after treatment for malignant neoplasms

199

1.92

3.52

1.3

1.1

27.55

24.31

u/l

0.14

161

Other disorders starting during childhood or adolescence

3.03

3.47

1.4

1.1

11.00

28.85

u/l

0.51

Complications of the puerperium, not elsewhere classified

2.90

3.46

1.5

1.1

10.80

30.41

u/l

0.66

Congenital malformations of genital organs

151

2.05

3.45

1.1

1.2

13.65

20.70

u/l

0.61

132

Fall on and from stairs and steps

567

1.52

3.44

1.2

36.71

22.78

u/l

1.15

473

Poisoning by medicine

433

1.60

3.43

1.2

30.64

20.33

u/l

0.63

371

Other diseases of upper respiratory tract

398

1703

1.22

3.39

1.3

1.2

22.95

25.52

u/l

0.39

341

1470

Syphilis

3.12

3.38

1.3

1.2

40.00

14.53

u/l

0.99

Hallux rigidus

297

1.72

3.38

1.2

23.24

21.73

u/l

0.08

249

Enthesopathies of lower limb, excluding foot

506

1.55

3.37

1.3

1.2

20.59

23.27

u/l

0.26

425

Pneumonia due to Streptococcus pneumoniae

2.85

3.36

1.5

1.2

18.73

18.55

u/l

0.01

Zoster [herpes zoster]

366

1.64

3.35

1.3

1.2

33.38

25.73

u/l

0.40

309

Superficial injury of lower leg

515

1.54

3.34

1.3

1.2

25.86

22.23

u/l

0.23

439

Anterior Iridocyclitis

444

1.58

3.34

1.2

25.44

22.18

u/l

0.23

374

Carcinoma in situ of breast, intraductal

182

1.93

3.33

1.3

1.2

10.67

18.05

u/l

1.79

150

Ankylosing spondylitis, strict definition

2.73

3.32

1.1

12.88

13.24

u/l

0.04

Other chronic obstructive pulmonary disease

140

844

1.38

3.32

1.2

35.58

25.38

u/l

0.96

117

716

Other disorders of eye and adnexa

269

1.75

3.31

1.4

1.2

16.80

21.39

u/l

0.39

232

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

141

2.06

3.31

1.2

56.00

22.31

u/l

0.66

119

Other other unspecified disorders of the circulatory system

2.64

3.31

1.4

1.2

13.50

18.84

u/l

0.38

Iridocyclitis

501

1.54

3.29

1.2

27.75

22.58

u/l

0.38

421

Later onset COPD, excluding more controls

272

1.67

3.29

1.2

1.3

28.14

22.36

u/l

0.54

222

Superficial injury of shoulder and upper arm

190

1.90

3.28

1.3

1.2

28.77

18.59

u/l

0.31

161

Infections with a predominantly sexual mode of transmission

622

1.48

3.27

1.2

24.64

18.17

u/l

0.50

538

Fracture of foot, except ankle

478

1.55

3.27

1.5

1.2

28.83

20.84

u/l

0.69

408

Ptosis of eyelid

219

1.83

3.26

1.2

35.25

19.02

u/l

0.75

190

Oter anti-inflammatory and antirheumatic agents, non-steroids

290

1.55

3.25

1.2

22.59

26.98

u/l

0.28

259

Acute pharyngitis

225

1.81

3.24

1.5

1.2

15.09

23.34

u/l

0.71

188

Melanocytic naevi of trunk

206

1.85

3.20

1.2

1.1

31.97

22.84

u/l

0.33

176

Sensorineural hearing loss

170

1567

0.76

3.16

1.4

1.2

24.26

25.63

u/l

0.14

152

1334

Other neurological diseases

241

1529

1.27

3.16

1.2

28.04

25.37

u/l

0.30

208

1304

Acute and subacute iridocyclitis

419

1.58

3.16

1.2

26.07

22.18

u/l

0.27

351

Other obstructive and reflux uropathy

2.74

3.15

1.1

1.2

11.27

31.79

u/l

0.80

Hemiplegia

2.37

3.15

1.3

1.2

26.85

17.38

u/l

0.53

Problems related to lifestyle

151

1.99

3.14

1.1

34.55

26.58

u/l

0.20

127

Delivery, wide proxy

553

0.64

3.14

1.3

1.2

27.86

23.42

u/l

0.15

483

Other crystal arthropathies

4.55

3.12

1.1

8.11

15.36

u/l

—

135

929

1.37

3.11

1.2

31.37

26.83

u/l

0.55

115

785

Injuries to the wrist and hand

326

1929

1.23

3.11

1.2

26.45

23.92

u/l

0.30

275

1679

Malignant neoplasm of respiratory system and intrathoracic organs

373

1.58

3.06

1.1

1.2

37.39

25.89

u/l

0.65

314

Superficial injury of wrist and hand

368

1.61

3.05

1.1

1.2

20.57

19.77

u/l

0.05

319

Other and unspecified follicular disorders

2.60

3.05

1.2

18.67

16.89

u/l

—

Colonic or urogenital fistula

633

1.46

3.04

1.1

1.2

17.77

22.87

u/l

0.80

530

Sleep apnoea

316

1749

1.23

3.02

1.2

22.42

25.56

u/l

0.69

273

1504

Rheumatic fever with heart involvement

10.23

2.99

1.2

23.60

21.40

u/l

—

Diffuse large B-cell lymphoma

2.42

2.97

1.2

31.50

18.26

u/l

0.57

Alcohol dependence

530

1.49

2.97

1.1

1.3

39.45

25.22

u/l

0.90

448

Other respiratory disorders and diseases

387

1.58

2.95

1.4

1.2

35.26

25.93

u/l

0.70

323

Other diseases of the respiratory system

387

1.58

2.95

1.4

1.2

35.26

25.93

u/l

0.70

323

Fracture at wrist and hand level

103

728

1.42

2.94

1.1

1.2

27.87

21.23

u/l

0.46

626

Ventral hernia

532

1.49

2.92

1.3

1.2

39.35

23.80

u/l

0.89

441

Pustulosis palmaris et plantaris

2.33

2.91

1.2

1.1

19.37

15.28

u/l

0.25

Dislocation, sprain and strain of joints and ligaments of thorax

2.71

2.89

1.3

1.2

23.36

18.40

u/l

0.24

Other diseases of oesophagus

156

1.93

2.89

1.5

1.1

18.59

16.22

u/l

0.23

129

Crystal arthropathies, rheuma endpoint

4.13

2.89

1.1

1.0

8.11

17.50

u/l

—

Non-small cell lung cancer

296

1.66

2.89

1.1

1.2

29.05

27.92

u/l

0.05

251

Abnormal findings in secretions and smears from cervix uteri vagina vulva

160

953

1.32

2.88

1.2

22.29

19.83

u/l

0.16

136

836

Other inflammation of eyelid

266

1.70

2.88

1.3

1.1

15.32

21.05

u/l

0.75

228

Benign neoplasm of breast

251

1.72

2.87

1.2

17.58

21.95

u/l

0.47

210

Use of anticholinesterases

568

0.60

2.85

1.1

1.2

29.83

29.25

u/l

0.03

477

N06DA Anticholinesterases

568

0.60

2.85

1.1

1.2

29.83

29.25

u/l

0.03

477

Other blood glucose lowering drugs, excl. Insulins

375

1.58

2.85

1.2

27.25

20.70

u/l

0.40

314

Coronary angioplasty

114

631

1.39

2.83

1.2

1.3

30.40

28.57

u/l

0.14

101

523

Coxibs

353

1.45

2.82

1.1

1.2

17.98

25.34

u/l

1.41

321

Sleep apnoea, including avohilmo

332

1780

1.21

2.82

1.2

21.12

25.44

u/l

1.21

286

1536

Myocardial infarction, with ST-elevation

314

1.63

2.80

1.2

1.3

49.12

25.20

u/l

1.04

256

Carpal tunnel syndrome

212

1515

1.26

2.80

1.3

1.2

19.81

24.01

u/l

1.08

191

1297

Generalized skin eruption due to drugs and medicaments

2.56

2.79

1.1

39.33

14.43

u/l

1.17

Chondropathies

315

1.62

2.77

1.2

1.1

27.18

21.22

u/l

0.46

269

Disorders of breast

176

1267

1.29

2.73

1.2

19.25

22.10

u/l

0.27

154

1094

Hypothyroidism, strict autoimmune, 3 medication purchases required

287

1601

1.22

2.73

1.2

23.68

23.08

u/l

0.07

253

1368

Suicide or other Intentional self-harm

524

1.47

2.73

1.2

33.51

20.08

u/l

0.83

447

Dermatographic urticaria

111

2.08

2.72

1.4

1.1

13.53

22.14

u/l

0.56

Sequelae of injuries, of poisoning and of other consequences of external causes

517

1.47

2.70

1.2

23.42

21.34

u/l

0.13

442

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

325

1.60

2.70

1.1

1.2

47.72

20.28

u/l

1.18

268

Benign neoplasm of eye and adnexa

189

1.81

2.70

1.1

1.2

18.66

19.49

u/l

0.04

164

severe traumatic brain injury, does not include concussion

420

1.53

2.70

1.2

23.17

26.05

u/l

0.23

347

Pustular psoriasis

2.19

2.67

1.2

19.85

17.53

u/l

0.13

COPD, hospital admissions

140

894

1.33

2.66

1.2

1.3

35.58

28.44

u/l

0.57

117

752

COPD related to multimorbidity

120

745

1.36

2.65

1.1

1.3

35.41

27.85

u/l

0.56

102

628

Barrett oesophagus

2.34

2.65

1.1

1.2

17.50

16.00

u/l

—

Complications of labour and delivery

149

1087

0.76

2.65

1.2

14.45

22.21

u/l

2.74

127

941

COPD-related respiratory insufficiency

220

1.73

2.64

1.1

1.3

43.91

25.04

u/l

0.59

185

Dental caries 2

244

1553

1.24

2.61

1.3

1.2

19.44

21.36

u/l

0.35

213

1341

Basal cell carcinoma, including avohilmo

190

1178

1.27

2.61

1.2

28.96

25.84

u/l

0.40

161

1000

Other disorders of lacrimal gland

118

875

1.35

2.59

1.2

23.40

21.83

u/l

0.10

747

Unspecific neurodegenerative disorder

648

0.67

2.57

1.1

1.2

35.88

28.78

u/l

0.45

549

Dentofacial anomalies [including malocclusion]

542

1.44

2.55

1.3

1.2

20.32

20.37

u/l

0.00

456

Pneumococcal septicemia

2.62

2.53

1.6

1.2

25.69

18.68

u/l

0.58

Other specified disorders of kidney and ureter

2.52

2.53

1.1

19.14

16.38

u/l

0.14

Somnolence, stupor and coma

2.28

2.51

1.3

1.2

38.75

17.97

u/l

0.61

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

609

1.41

2.50

1.2

30.91

18.94

u/l

0.81

524

Other chronic obstructive pulmonary disease, including avohilmo

169

1099

1.28

2.49

1.2

34.19

25.48

u/l

0.90

143

935

Other and unspecified disorders of vitreous body

142

1083

1.31

2.49

1.3

1.2

18.87

22.81

u/l

0.55

123

919

Artrosis, including avohilmo

286

1293

1.21

2.48

1.2

20.64

27.74

u/l

1.60

245

1122

Benign neoplasm: Other and unspecified parts of small intestine

4.42

2.48

1.0

1.1

10.57

21.09

u/l

—

Injury of eye and orbit

232

1.69

2.48

1.2

23.13

19.79

u/l

0.26

196

Polyarthrosis

442

1.48

2.47

1.2

27.16

22.06

u/l

0.28

376

Late syphilis

3.86

2.47

1.5

1.2

34.25

15.06

u/l

—

Pregnancy, childbirth and the puerperium

458

0.66

2.46

1.3

1.2

17.76

24.27

u/l

1.36

397

Diplopia

225

1.69

2.46

1.3

1.2

33.29

19.72

u/l

0.45

190

Idiopathic thrombocytopenic purpura

2.68

2.45

1.3

1.1

35.33

15.22

u/l

0.88

Adverse effects, not elsewhere classified

398

1.51

2.44

1.3

1.2

15.54

20.77

u/l

0.78

346

Malignant neoplasm of kidney, except renal pelvis

159

1.83

2.43

1.2

1.3

36.25

18.04

u/l

1.15

135

D07AA Corticosteroids, weak (group I)

272

1.62

2.41

1.1

1.2

26.87

20.90

u/l

0.45

234

Other disorders of the genitourinary system

304

1.58

2.40

1.3

1.2

10.47

21.86

u/l

3.39

259

COPD, early/later onset

140

907

1.30

2.40

1.2

1.3

35.58

28.26

u/l

0.59

117

765

Rotator cuff syndrome

196

1163

1.25

2.40

1.3

1.2

25.71

25.60

u/l

0.01

168

995

Other and unspecified rosacea

160

1.82

2.39

1.2

11.12

20.10

u/l

1.55

138

Basal cell carcinoma

183

1158

1.26

2.38

1.2

29.56

25.87

u/l

0.48

156

982

Acute and transient psychotic disorders

235

1.66

2.38

1.1

1.2

16.21

23.17

u/l

0.64

199

Benign neoplasm: Small intestine

2.22

2.38

1.2

19.29

18.03

u/l

0.08

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

183

1187

1.26

2.37

1.2

23.18

20.46

u/l

0.21

158

1028

Autism spe

3.66

2.36

1.6

1.2

9.00

8.53

u/l

—

Granulomatous disorders of skin and subcutaneous tissue

2.63

2.36

1.6

1.1

25.00

14.70

u/l

0.36

Melanoma in situ

2.51

2.36

1.2

1.1

52.69

17.82

u/l

0.70

Attention to artificial openings

2.62

2.36

1.7

1.2

34.33

16.41

u/l

0.90

Diseases of external ear

102

753

1.36

2.34

1.3

1.2

24.55

22.71

u/l

0.13

629

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

169

1.78

2.32

1.1

1.2

66.52

19.60

u/l

1.13

141

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

331

1.54

2.31

1.1

1.2

13.45

18.73

u/l

0.84

291

Carcinoma in situ of breast, intraductal

207

1.70

2.30

1.3

1.2

10.67

19.67

u/l

1.60

180

Benign neoplasm of urinary organs

2.38

2.29

1.4

1.1

20.36

16.30

u/l

0.30

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

530

1.42

2.29

1.1

1.2

13.40

19.99

u/l

1.59

459

Skin changes due to chronic exposure to nonionizing radiation

123

887

1.31

2.27

1.2

33.17

26.73

u/l

0.80

104

748

Spondylolisthesis/Spondylolysis

430

1.47

2.26

1.4

1.2

22.57

20.95

u/l

0.12

353

Other disorders of nervous system

120

1.93

2.25

1.5

1.2

17.22

21.55

u/l

0.37

103

Other and unspecified myopathies

149

1.82

2.24

1.2

25.86

17.50

u/l

0.86

125

Dental caries 2 and operation codes

236

1543

1.22

2.23

1.3

1.2

19.56

21.39

u/l

0.32

205

1334

Actinic keratosis

120

868

1.31

2.23

1.2

33.41

27.09

u/l

0.75

101

731

Benign neoplasm: Kidney

2.63

2.19

1.2

1.1

14.45

15.50

u/l

0.08

Other inflammation of vagina/vulva

2.63

2.18

1.2

1.1

33.00

15.97

u/l

0.34

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.63

2.18

1.2

10.73

10.94

u/l

0.02

Malignant neoplasm of urinary organs

173

1.74

2.16

1.2

34.92

19.18

u/l

0.97

146

Malignant neoplasm of skin

203

1245

1.23

2.13

1.3

1.2

28.72

25.02

u/l

0.54

176

1052

Dermatitis due to substances taken internally

2.11

2.12

1.2

37.06

15.16

u/l

1.16

Graves disease, strict definition

197

1.68

2.11

1.2

1.1

13.26

21.44

u/l

0.75

172

Other neurotic disorders

2.06

2.11

1.6

1.2

14.54

16.22

u/l

0.08

Other epidermal thickening

2.22

2.11

1.4

1.2

19.27

17.68

u/l

0.10

Benign neoplasm: Duodenum

2.58

2.10

1.3

1.1

23.64

17.31

u/l

0.35

ILD-related respiratory insufficiency

2.57

2.10

1.0

1.2

90.55

24.06

u/l

0.87

Autism

3.22

2.09

1.6

1.2

9.00

9.55

u/l

—

LSIL lesion of the cervix uteri, vagina or vulva

268

1.57

2.08

1.2

25.34

17.66

u/l

0.26

233

Conductive and sensorineural hearing loss

193

1634

0.82

2.05

1.3

1.2

27.20

25.99

u/l

0.10

174

1392

Other hammer toe(s) (acquired)

381

1.46

2.04

1.1

1.2

29.19

22.28

u/l

0.58

320

Cervicalgia

457

1.43

2.03

1.2

18.80

22.26

u/l

0.38

375

Atrophic disorders of skin

326

1.51

2.03

1.2

18.44

22.84

u/l

0.31

277

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

318

1.51

2.02

1.2

25.58

21.29

u/l

0.18

275

Seborrhoeic keratosis

483

1.41

2.01

1.4

1.2

24.11

22.97

u/l

0.07

398

Contusion of toe(s) without damage to nail

3.09

2.01

1.6

1.3

19.25

13.67

u/l

—

Transient ischemic attack

167

1115

1.24

1.99

1.1

1.2

30.11

25.23

u/l

0.44

141

951

Other abnormal immunological findings in serum

2.98

1.94

1.1

15.38

11.82

u/l

—

Bacterial, viral and other infectious agents

142

1.77

1.92

1.2

1.1

25.11

17.39

u/l

0.53

123

Nummular dermatitis

135

1.78

1.91

1.7

1.1

33.94

20.25

u/l

0.46

112

Meniscus derangement

166

919

1.24

1.88

1.2

1.3

21.22

27.37

u/l

1.11

144

789

Occupational exposure to risk-factors

0.00

1.87

0.0

1.2

—

19.36

—

Malignant neoplasm of bronchus and lung

326

1.47

1.86

1.1

1.2

31.98

28.47

u/l

0.17

275

Epilepsy

687

1.32

1.84

1.2

28.79

23.23

u/l

0.30

586

Oxicams

314

1.38

1.84

1.1

1.2

23.17

27.60

u/l

0.25

282

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

101

775

1.30

1.83

1.3

1.2

21.01

19.72

u/l

0.10

667

Other benign neoplasms of skin

736

1.31

1.83

1.3

1.2

20.23

23.00

u/l

0.34

621

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

311

1.40

1.82

1.3

1.2

21.31

17.04

u/l

0.14

277

Atopic dermatitis, strict definition with reimbursement

577

1.35

1.82

1.2

24.17

18.17

u/l

0.26

499

Spirochaetal infections, other/unspecified

160

1.69

1.81

1.2

1.1

19.76

20.50

u/l

0.05

139

Migraine with aura

502

1.38

1.81

1.3

1.2

17.40

19.76

u/l

0.29

433

Ganglion

477

1.39

1.80

1.2

16.15

22.50

u/l

1.08

411

Umbilical hernia

520

1.37

1.79

1.2

1.3

35.49

24.86

u/l

0.72

442

Other extrapyramidal and movement disorders in other diseases

495

1.38

1.78

1.3

1.2

16.35

23.19

u/l

1.20

414

Mouth breathing

120

947

1.27

1.78

1.2

1.3

26.57

22.75

u/l

0.29

107

806

Benign neoplasm of breast

289

1.49

1.74

1.2

17.58

21.83

u/l

0.48

245

569

1.33

1.74

1.3

1.2

30.41

27.31

u/l

0.17

485

False labour

427

0.69

1.73

1.2

7.85

20.04

u/l

6.38

376

Unspecified event, undetermined intent

2.68

1.72

1.0

1.3

10.25

13.60

u/l

—

Acute suppurative otitis media

402

1.40

1.71

1.3

1.2

29.42

17.83

u/l

0.43

348

Haemorrhoids and perianal venous thrombosis

611

1.33

1.70

1.2

26.45

21.98

u/l

0.39

512

Temporomandibular joint disorders

283

1.49

1.68

1.3

1.2

19.39

20.85

u/l

0.11

239

Colorectal cancer, excluding all cancers (controls excluding all cancers)

501

1.35

1.67

1.2

39.49

23.16

u/l

0.90

423

Acute epiglottitis

3.18

1.66

1.2

48.17

10.36

u/l

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

3.18

1.66

1.3

1.1

44.17

21.29

u/l

—

Maternal care for known or suspected malpresentation of fetus

238

0.56

1.65

1.4

1.2

18.22

16.49

u/l

0.05

210

Ovarian cyst

130

602

1.25

1.62

1.3

1.2

21.46

22.42

u/l

0.11

112

518

Other and unspecified nail disorders

2.52

1.60

1.5

1.1

42.88

14.77

u/l

—

Superficial injury of ankle and foot

198

1.57

1.59

1.4

1.2

21.42

22.19

u/l

0.04

172

Emotional disorders and disorders of social functioning with onset specific to childhood

2.22

1.58

1.4

1.2

10.00

31.44

u/l

0.72

Other problems related to primary support group, including family circumstances

170

1.61

1.58

1.1

1.2

17.19

21.19

u/l

0.24

147

Other malignant neoplasms of skin (=non-melanoma skin cancer)

170

1115

1.20

1.57

1.3

1.2

29.08

26.15

u/l

0.35

146

945

Olecranon bursitis

1.82

1.57

1.2

13.50

22.88

u/l

1.36

Other and unspecified nonorganic psychotic disorders

363

1.41

1.56

1.1

1.2

10.64

20.58

u/l

2.37

317

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

152

1228

1.21

1.55

1.2

20.43

24.90

u/l

0.59

134

1047

Impetigo

2.11

1.55

1.6

1.1

42.92

13.65

u/l

0.91

Other and unspecified effects of external causes

569

1.32

1.55

1.3

1.2

15.80

19.95

u/l

0.73

487

Suggestive for eosinophilic asthma

169

1.60

1.51

1.1

16.35

17.50

u/l

0.09

141

Excessive, frequent and irregular menstruation

135

611

1.23

1.48

1.2

18.98

22.32

u/l

0.43

117

524

Inflammatory diseases of female pelvic organs

202

1294

1.18

1.46

1.3

1.2

20.64

21.37

u/l

0.06

175

1124

Paracetamol of NSAID medication

161

1.44

1.45

1.2

16.54

20.56

u/l

0.43

144

COPD, hospital admissions 1, only main diagnosis

654

1.26

1.44

1.1

1.3

33.27

28.37

u/l

0.33

547

Toxic effect of ethanol

2.12

1.44

1.0

1.2

87.20

13.29

u/l

—

Early syphilis

3.15

1.44

1.0

1.2

49.20

15.82

u/l

—

Other obstetric conditions, not elsewhere classified

326

1.34

1.44

1.3

1.2

21.21

17.38

u/l

0.13

290

Dementia

694

0.77

1.43

1.2

40.48

27.77

u/l

0.74

587

Plantar fascial fibromatosis

212

1.51

1.43

1.2

24.16

16.11

u/l

0.44

187

Disorders of lacrimal system

134

1104

1.22

1.42

1.2

23.82

22.49

u/l

0.09

110

936

LSIL lesion of the cervix uteri

188

1.55

1.42

1.1

1.2

12.58

21.37

u/l

0.91

164

Acute nephritic syndrome

2.26

1.40

1.2

1.1

31.89

16.15

u/l

—

Benign neoplasm: Other and unspecified parts of small intestine

2.43

1.39

1.0

1.2

10.57

25.09

u/l

—

Dementia, including avohilmo

760

0.79

1.39

1.2

37.67

27.50

u/l

0.64

648

Unspecified mental disorder

120

980

1.23

1.39

1.1

1.3

17.14

21.13

u/l

0.55

104

836

Single delivery by caesarean section

273

0.68

1.36

1.2

1.3

9.33

20.06

u/l

4.25

246

Other disorders of breast

298

1.41

1.35

1.3

1.2

26.03

22.23

u/l

0.09

258

Anorexia (incl.atypical)

1.87

1.34

1.4

1.2

16.50

26.74

u/l

0.41

Contact with sharp glass

2.13

1.33

1.1

1.2

18.60

12.54

u/l

—

Melanoma in situ

1.92

1.33

1.2

52.69

18.92

u/l

0.67

Malignant neoplasm of head and neck

144

1.60

1.31

1.3

1.2

39.59

19.49

u/l

0.36

122

Maternal care related to the fetus and amniotic cavity and possible delivery problems

100

729

0.81

1.31

1.2

19.96

19.95

u/l

0.00

642

Alzheimer disease

465

0.73

1.31

1.1

1.2

34.50

29.46

u/l

0.24

394

Cervical disc disorders

107

871

1.23

1.30

1.2

20.05

23.43

u/l

0.29

736

Wide developmental disorders

2.36

1.29

1.6

1.1

9.00

9.59

u/l

—

Car occupant injured in other and unspecified transport accidents

361

1.36

1.27

1.2

31.33

20.43

u/l

0.28

315

Deficiency of other B group vitamins

2.30

1.27

1.3

1.1

13.75

17.07

u/l

—

Foreign body entering into or through eye or natural orifice

130

1.62

1.26

1.8

1.2

21.44

20.05

u/l

0.07

110

Rosacea

227

1.46

1.26

1.2

1.1

13.96

21.78

u/l

0.92

194

Calculus of lower urinary tract

1.82

1.25

1.1

8.86

19.60

u/l

2.67

Focal brain injury

100

1.70

1.23

1.1

1.3

22.83

18.29

u/l

0.18

Non-Hodgkin lymphoma, all

1.97

1.22

1.5

1.2

68.27

19.81

u/l

1.21

Open wound of wrist and hand

111

906

1.21

1.2

1.3

38.61

22.11

u/l

1.00

786

402

1.32

1.21

1.3

1.2

26.53

29.69

u/l

0.24

338

General examination and investigation of persons without complaint and reported diagnosis

164

741

1.18

1.20

1.2

31.92

24.08

u/l

0.62

146

632

Abnormal involuntary movements

255

1.41

1.19

1.3

1.2

13.78

19.46

u/l

0.77

216

Foreign body in alimentary tract

1.75

1.19

1.3

1.1

29.30

19.25

u/l

—

Cerebral cysts

1.75

1.19

1.1

1.2

27.40

18.24

u/l

0.50

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

603

1.26

1.18

1.3

1.2

20.51

19.55

u/l

0.09

522

Gestational diabetes (for exclusion)

507

1.24

1.17

1.2

14.38

18.73

u/l

0.82

444

Other and unspecified hydrocephalus

0.00

1.16

0.0

1.2

—

16.30

—

Suppurative otitis media, unspecified

0.00

1.15

0.0

1.2

—

14.17

—

Malignant neoplasm of colon

283

1.38

1.14

1.1

1.2

57.47

25.43

u/l

0.97

237

Superficial injury of thorax

275

1.38

1.13

1.2

1.1

29.74

25.48

u/l

0.20

226

Chronic laryngitis and laryngotracheitis

310

1.36

1.11

1.2

20.36

18.90

u/l

0.11

254

Hidradenitis suppurativa

1.97

1.11

1.3

1.2

45.50

13.64

u/l

—

Atopic dermatitis, strict definition

588

1.25

1.11

1.2

24.93

17.68

u/l

0.31

514

Fistulae involving female genital tract

2.27

1.10

1.1

1.2

6.00

12.68

u/l

—

Hallux valgus (acquired)

103

616

1.21

1.09

1.2

15.88

22.02

u/l

1.33

529

Benign neoplasm of urinary organs

1.73

1.09

1.4

1.1

20.36

16.79

u/l

0.25

Medical abortion

215

1023

1.14

1.09

1.2

28.00

21.31

u/l

0.67

187

878

Other bursopathies

269

1.38

1.08

1.4

1.2

21.31

21.27

u/l

0.00

228

Benign neoplasm: Kidney

1.87

1.07

1.2

14.45

17.10

u/l

0.23

Burn and corrosion of wrist and hand

1.93

1.06

1.1

10.60

14.22

u/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

122

0.49

1.05

1.5

1.2

7.00

27.06

u/l

—

109

Iridocyclitis in diseases classified elsewhere

2.28

1.03

1.2

1.1

70.20

12.63

u/l

—

Other disorders of pigmentation

1.74

1.03

1.2

22.31

15.35

u/l

0.50

Other abnormal products of conception

476

0.78

1.02

1.3

1.2

10.86

18.52

u/l

2.73

419

Benign neoplasm: Conjunctiva

1.92

1.02

1.2

1.1

27.89

17.61

u/l

—

Postmenopausal atrophic vaginitis

103

516

1.20

1.00

1.2

17.30

22.55

u/l

0.74

440

Alcohol abuse, main dg, excluding more controls

248

1.37

0.99

1.1

1.2

35.21

20.02

u/l

0.74

210

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.81

0.98

1.4

1.1

79.45

14.34

u/l

0.75

Benign mammary dysplasia

370

1.30

0.98

1.3

1.2

13.90

23.62

u/l

2.11

310

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

2.18

0.98

1.0

1.2

17.60

16.00

u/l

—

Emotional disorders starting during childhood or adolescence

1.83

0.97

1.2

11.22

15.47

u/l

—

Deviated nasal septum

729

1.21

0.97

1.4

1.2

30.90

23.85

u/l

0.41

623

Wet age-related macular degeneration

321

1.32

0.96

1.3

1.2

34.34

27.62

u/l

0.22

265

Other and unspecified tonsillitis

495

1.23

0.96

1.2

30.19

21.78

u/l

0.51

427

Kela-code for severe mental illness

102

858

1.19

0.96

1.1

1.2

17.65

21.53

u/l

0.43

733

Other noninflammatory disorders of vulva and perineum

207

1.40

0.96

1.2

31.46

19.95

u/l

0.27

177

Migraine

136

996

1.16

0.95

1.3

1.2

19.29

20.78

u/l

0.20

115

865

Migraine with aura and triptan purchases

293

1.33

0.95

1.3

1.2

18.61

20.01

u/l

0.10

259

Coxarthrosis, primary

185

1414

1.14

0.95

1.2

23.90

24.88

u/l

0.13

154

1205

Alzheimer disease, including avohilmo

541

0.80

0.94

1.1

1.2

30.46

29.30

u/l

0.06

461

Paraplegia, diplegia of upper limbs

1.90

0.94

1.4

1.2

28.86

14.32

u/l

—

Internal derangement of knee

767

1.20

0.93

1.2

1.3

21.67

25.42

u/l

0.47

653

Leiomyoma of uterus

219

1107

1.13

0.93

1.3

1.2

19.57

22.21

u/l

0.37

187

956

Cluster headache, strict

1.82

0.92

1.5

1.1

6.30

15.81

u/l

—

Use of memantine

415

0.75

0.92

1.1

1.2

42.21

31.47

u/l

0.45

347

Use of other anti-dementia drugs

415

0.75

0.92

1.1

1.2

42.21

31.47

u/l

0.45

347

Other and unspecified nerve root and plexus disorders, also in other diseases

407

0.74

0.91

1.2

15.36

22.10

u/l

0.83

342

Other and unspecified epidermal thickening

1.91

0.88

1.5

1.2

15.13

19.64

u/l

—

Major anomalies of jaw size

1.91

0.88

1.0

1.2

11.75

11.09

u/l

—

Myocardial infarction, unclassifiable

391

1.26

0.88

1.2

45.56

28.16

u/l

0.84

325

Psoriasis (vulgaris), strict definition

1.87

0.87

1.1

24.88

15.25

u/l

—

Postmenopausal bleeding

111

519

1.18

0.87

1.2

28.47

22.58

u/l

0.39

440

Other fall from one level to another

413

1.26

0.86

1.5

1.2

18.20

23.52

u/l

0.75

347

Any dementia

597

0.83

0.84

1.2

40.52

27.98

u/l

0.70

510

Female infertility, cervigal, vaginal, other or unspecified origin

464

1.20

0.84

1.2

25.62

21.73

u/l

0.16

406

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

1.88

0.82

1.0

1.1

31.00

17.30

u/l

—

Alzheimer’s disease (Late onset)

352

0.75

0.81

1.1

1.2

36.35

32.31

u/l

0.14

296

Contact with and exposure to communicable diseases

586

0.80

0.81

1.3

1.2

31.33

17.54

u/l

0.36

515

Suppurative and unspecified otitis media

620

1.19

0.80

1.3

1.2

24.70

18.07

u/l

0.33

536

Obstructed labour due to malposition and malpresentation of fetus

469

0.78

0.79

1.2

11.44

21.88

u/l

2.49

410

Migraine without aura

401

1.25

0.79

1.1

1.2

11.76

18.38

u/l

1.49

356

Effects of foreign body entering through natural orifice

466

1.22

0.76

1.3

21.30

22.41

u/l

0.08

394

Other specific arthropathies, wide

1.77

0.76

1.2

1.1

15.67

13.54

u/l

—

Tooth agenesis EXCLUDE clefts and syndromes

1.77

0.76

1.2

35.50

39.90

u/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

599

1.20

0.76

1.2

32.24

17.41

u/l

0.59

521

Colon adenocarcinoma

226

1.33

0.76

1.1

1.2

66.52

24.27

u/l

0.97

187

Disorders of eyelid in diseases classified elsewhere

1.70

0.76

1.0

1.2

12.50

14.90

u/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

323

1.27

0.75

1.1

1.2

52.06

21.98

u/l

0.98

270

Polyp of the female genital tract

111

559

1.16

0.74

1.2

19.80

23.03

u/l

0.26

476

Female genital prolapse

551

0.85

0.74

1.1

1.2

14.55

22.96

u/l

2.01

468

Other spirochaetal diseases

633

1.19

0.74

1.1

1.2

17.79

21.67

u/l

0.64

529

Focal epilepsy

423

1.23

0.73

1.2

26.43

23.02

u/l

0.13

355

Diseases of male genital organs

128

566

1.14

0.73

1.3

35.60

27.85

u/l

0.55

108

490

Abnormal findings on diagnostic imaging of breast

2.01

0.73

1.0

1.2

14.00

19.00

u/l

—

Glaucoma-related operations

100

1.50

0.73

1.1

1.2

35.22

18.36

u/l

—

Lichen planus, including avohilmo

424

1.23

0.73

1.3

1.2

34.91

21.49

u/l

0.69

351

Juvenile osteochondrosis

1.80

0.72

1.4

1.2

10.86

11.85

u/l

—

Dissociative [conversion] disorders

1.80

0.72

1.1

8.86

35.45

u/l

—

Benign neoplasm: Conjunctiva

1.61

0.72

1.2

27.89

15.37

u/l

—

Irregular menses

139

998

1.13

0.72

1.2

16.68

19.80

u/l

0.67

126

859

Degenerative diseases of the nervous system

543

0.83

0.71

1.2

34.91

28.24

u/l

0.32

462

Other disorders of ear

249

1813

0.91

0.70

1.3

1.2

23.27

25.38

u/l

0.26

216

1557

Lyme disease

627

1.18

0.70

1.1

1.2

17.00

21.76

u/l

0.87

525

Lesion of ulnar nerve

292

1.27

0.69

1.2

20.81

20.96

u/l

0.01

245

Toxic effects of substances chiefly nonmedicinal as to source

187

1.34

0.68

1.0

1.2

32.71

24.61

u/l

0.16

158

Persons encountering health services in other circumstances

778

1.16

0.67

1.3

1.2

32.28

21.35

u/l

1.23

649

Acute appendicitis, no complications

152

1358

1.12

0.67

1.2

1.3

24.36

22.49

u/l

0.21

132

1163

Dental caries 2 and operation codes, only avohilmo

183

1256

0.90

0.67

1.3

19.46

24.09

u/l

1.06

156

1096

Strabismus

557

1.18

0.66

1.4

1.2

27.28

21.61

u/l

0.35

474

Other strabismus

438

1.21

0.65

1.4

1.2

19.51

21.34

u/l

0.12

377

Congenital malformations of the circulatory system

242

1.28

0.65

1.5

1.1

21.52

23.78

u/l

0.15

205

Glaucoma

169

1343

1.11

0.62

1.2

22.19

24.86

u/l

0.46

141

1139

Alzheimer’s disease, wide definition

393

0.81

0.62

1.1

1.2

30.00

30.83

u/l

0.03

333

Impacted cerumen

164

1.34

0.62

1.0

1.2

12.12

15.65

u/l

0.58

143

Glucosamine medication

132

1177

0.89

0.62

1.2

18.18

25.26

u/l

1.13

106

997

Outcome of delivery

216

1.23

0.62

1.1

1.3

12.06

16.67

u/l

1.17

190

Cluster headache, wide

1.59

0.61

1.5

1.1

6.30

14.72

u/l

—

Superficial injury of forearm

147

1.36

0.61

1.2

17.71

23.34

u/l

0.32

124

Female infertility

478

1.15

0.60

1.2

25.04

22.44

u/l

0.11

416

Acetic acid derivatives and related substances

349

1.16

0.60

1.1

1.2

26.09

25.61

u/l

0.02

317

Benign neoplasm: Skin, unspecified

1.57

0.60

1.4

1.2

12.75

19.78

u/l

—

Oligomenorrhoea

1.54

0.59

1.3

1.2

21.88

17.15

u/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

123

1092

1.12

0.58

1.3

1.2

21.73

21.59

u/l

0.01

109

929

Presence of other functional implants

160

1027

1.10

0.58

1.3

1.2

22.30

24.35

u/l

0.31

141

868

Benign lipomatous neoplasm

734

0.86

0.57

1.1

1.2

13.59

22.63

u/l

2.79

609

Extrapyramidal and movement disorders

100

886

1.13

0.56

1.3

1.2

22.27

24.53

u/l

0.15

745

Persons encountering health services in circumstances related to reproduction

166

1023

1.10

0.56

1.3

1.2

18.83

21.28

u/l

0.29

145

893

Benign neoplasm: Skin of eyelid, including canthus

283

1.24

0.56

1.2

12.79

19.15

u/l

1.45

233

Anti-inflammatory and antirheumatic products, non-steroids

372

1.15

0.56

1.1

1.2

26.60

24.54

u/l

0.11

339

Organic, including symptomatic, mental disorders

137

891

1.11

0.56

1.2

34.38

27.00

u/l

0.64

117

753

Cluster headache, strict, including avohilmo

1.51

0.56

1.5

1.2

6.55

15.41

u/l

4.65

Acute appendicitis

193

1672

1.09

0.55

1.2

1.3

31.42

23.00

u/l

0.94

170

1438

Cervicobrachial syndrome

513

1.17

0.55

1.1

1.2

32.31

23.00

u/l

0.43

430

Other predominantly sexually transmitted diseases, not elsewhere classified

320

1.22

0.55

1.2

14.03

19.23

u/l

0.62

277

Primary coxarthrosis, bilateral

698

0.86

0.54

1.2

21.18

25.68

u/l

0.59

583

Retinal breaks without detachment

339

1.21

0.54

1.3

1.2

22.47

21.61

u/l

0.06

288

Other melanin hyperpigmentation

1.58

0.54

1.3

1.2

15.83

19.06

u/l

—

Tuberculosis of other organs, strict

1.58

0.54

1.5

1.2

36.17

18.48

u/l

—

Long labour

459

0.84

0.54

1.4

1.2

19.00

20.26

u/l

0.10

401

Salpingitis and oophoritis

496

1.17

0.54

1.5

1.2

27.31

19.60

u/l

0.25

420

Tonsillectomy and adenotomy

117

908

0.90

0.54

1.4

1.2

24.07

18.08

u/l

0.36

102

800

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

622

0.85

0.54

1.2

1.3

18.70

21.51

u/l

0.29

530

Nasal polyp

413

1.19

0.54

1.2

20.22

20.45

u/l

0.02

346

Acute alcohol intoxication, ICD10

358

1.20

0.53

1.0

1.2

36.79

23.62

u/l

0.65

303

Desensitization to allergens

1.45

0.53

1.3

1.2

15.78

13.67

u/l

—

Appendicitis, broad definition

208

1757

1.08

0.53

1.2

29.81

23.36

u/l

0.71

185

1511

Gonarthrosis,primary

284

1669

1.07

0.51

1.2

23.24

25.97

u/l

0.47

234

1440

Diseases of appendix

209

1763

1.08

0.51

1.2

29.68

23.32

u/l

0.71

186

1516

Schizophrenia or delusion, excluding more controls

634

1.14

0.51

1.1

1.2

12.13

19.40

u/l

2.52

546

Diseases of middle ear and mastoid

142

1058

1.10

0.51

1.3

1.2

26.36

21.44

u/l

0.36

130

904

Achilles tendinitis

215

1.26

0.50

1.2

17.15

18.10

u/l

0.07

177

Alopecia areata

1.47

0.50

1.0

1.1

17.83

14.18

u/l

—

Combinations of oral blood glucose lowering drugs

631

1.14

0.50

1.2

1.3

37.49

20.68

u/l

1.13

526

Primary gonarthrosis, bilateral

156

1250

1.09

0.49

1.2

25.81

23.79

u/l

0.19

130

1069

Crowding of teeth, including avohilmo

1.38

0.49

1.3

25.67

20.78

u/l

0.14

All dysplastic lesions of the cervix uteri

500

1.16

0.49

1.2

27.73

17.19

u/l

0.36

435

Coxarthrosis, primary, with hip surgery

137

1184

1.10

0.48

1.2

23.57

25.39

u/l

0.22

114

1000

Inflammatory disease of uterus

289

1.21

0.48

1.2

15.37

18.51

u/l

0.22

255

Benign paroxysmal vertigo

727

1.13

0.48

1.2

23.35

23.71

u/l

0.02

612

Use of galantamine

111

0.63

0.48

1.1

1.2

38.43

27.12

u/l

—

Infective dermatitis

199

1.26

0.47

1.1

20.59

20.47

u/l

0.00

167

Endometriosis

111

595

1.11

0.47

1.2

26.85

22.66

u/l

0.20

100

511

Other sexually transmitted chlamydial diseases

1.47

0.47

1.1

1.2

8.50

31.09

u/l

—

Other benign neoplasms of connective and other soft tissue

155

1.29

0.46

1.4

1.2

15.27

18.87

u/l

0.55

135

Acute alcohol intoxication

495

1.15

0.46

1.1

1.3

31.16

23.36

u/l

0.44

422

Other bullous disorders

1.43

0.46

1.1

21.00

14.98

u/l

—

Alcohol abuse, main dg

282

1.21

0.46

1.1

1.2

35.21

24.94

u/l

0.43

235

Diabetes mellitus in pregnancy

411

1.14

0.45

1.3

1.2

17.30

21.51

u/l

0.51

360

Injuries to the neck

441

1.16

0.44

1.3

1.2

23.52

21.43

u/l

0.10

374

Labour and delivery complicated by fetal stress [distress]

271

0.84

0.43

1.4

1.2

13.79

19.73

u/l

0.60

239

Diseases of the ear and mastoid process

373

1791

1.05

0.43

1.3

1.2

21.91

24.62

u/l

0.42

324

1546

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.62

0.43

1.4

1.1

28.60

21.76

u/l

—

Vasomotor and allergic rhinitis

864

1.11

0.43

1.3

1.2

21.44

19.60

u/l

0.14

744

Puerperal sepsis

371

0.83

0.42

1.3

1.2

17.27

21.65

u/l

0.44

320

Chronic diseases of tonsils and adenoids

207

1402

0.93

0.42

1.3

1.2

19.88

22.94

u/l

0.31

178

1210

Malignant neoplasm of tongue

1.57

0.42

1.8

1.2

16.80

13.50

u/l

—

Glaucoma suspect

104

945

1.10

0.42

1.2

19.92

23.08

u/l

0.55

792

Chronic iridocyclitis

1.38

0.42

1.1

1.2

14.08

17.52

u/l

0.33

Congenital malformations of heart and great arteries

214

1.22

0.42

1.5

1.2

22.86

21.54

u/l

0.08

184

Gonarthrosis, primary, with knee surgery

170

1289

1.08

0.42

1.1

1.2

20.79

25.13

u/l

0.98

142

1103

Diseases of inner ear

157

1424

1.08

0.41

1.2

22.08

23.96

u/l

0.21

134

1208

Drug-induced adrenocortical insufficiency

1.52

0.41

1.2

22.40

15.30

u/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

1.52

0.41

1.0

1.1

13.40

12.68

u/l

—

Open bite

1.33

0.40

1.3

1.1

17.63

14.69

u/l

—

Any dementia, excluding more controls

537

0.89

0.40

1.2

41.00

26.30

u/l

0.85

456

Keratoconus

1.43

0.39

1.2

71.60

12.18

u/l

—

Dental caries 3 and operation codes, only avohilmo

452

0.90

0.38

1.0

1.3

18.51

26.34

u/l

1.40

408

Allergic contact dermatitis due to drugs in contact with skin

1.39

0.38

1.2

1.1

31.60

15.73

u/l

—

Pollen allergy

323

1.16

0.37

1.3

1.2

13.27

18.25

u/l

0.69

283

Polycystic ovarian syndrome, consortium definition

225

1278

1.06

0.37

1.2

20.28

21.80

u/l

0.21

205

1096

Pedal cyclist injured in transport accident

449

1.14

0.37

1.4

1.2

20.31

21.69

u/l

0.11

384

Temporomandibular joint disorders, including avohilmo

994

0.91

0.35

1.3

1.2

18.63

20.11

u/l

0.18

857

Lichen ruber planus, wide definition including periferal and oral lichen planus

517

1.12

0.35

1.3

1.2

33.45

22.43

u/l

0.60

433

Presbycusis

281

1.17

0.34

1.1

1.2

21.96

29.80

u/l

0.68

228

Obstructed labour due to maternal pelvic abnormality

447

0.87

0.34

1.4

1.2

15.16

21.58

u/l

0.84

386

Pedal cyclist injured in noncollision transport accidents

209

1.20

0.34

1.2

1.1

26.00

21.29

u/l

0.19

175

Disorders of vestibular function (Vertigo)

133

1231

1.07

0.33

1.2

23.65

23.58

u/l

0.01

113

1042

Benign neoplasm: Other and unspecified parts of mouth

1.31

0.33

1.5

1.1

33.33

17.46

u/l

—

Benign neoplasm of meninges

182

1.21

0.33

1.6

1.2

19.41

17.06

u/l

0.18

157

Endometriosis of ovary

424

1.13

0.33

1.3

1.2

40.64

20.81

u/l

0.51

360

Burn and corrosion of trunk

1.28

0.32

1.2

10.83

15.15

u/l

—

Muscle strain

1.28

0.32

1.5

1.2

8.00

21.39

u/l

—

Other specified/unspecified soft tissue disorders

1.33

0.32

1.3

1.2

68.27

18.55

u/l

0.65

Cluster headache, wide,, including avohilmo

1.33

0.32

1.5

1.1

6.55

15.67

u/l

5.12

Assault by bodily force

119

1.26

0.31

1.5

1.2

24.13

25.61

u/l

0.04

102

Cerebral aneurysm, nonruptured

174

1.21

0.31

1.2

1.1

10.73

19.51

u/l

1.45

153

Malignant neoplasm of ovary

0.71

0.30

1.3

1.2

27.71

20.74

u/l

—

Hyperplasia of prostate

428

1.09

0.30

1.3

42.81

28.63

u/l

0.76

366

Dysplasia of cervi uteri

441

1.11

0.30

1.2

1.3

24.76

22.04

u/l

0.08

385

Unspecified abortion

120

1.25

0.30

1.2

1.1

23.67

13.34

u/l

0.62

105

Aneurysms, operations, SAH

357

0.87

0.30

1.2

15.67

20.75

u/l

0.90

300

Viral meningitis

1.27

0.30

1.3

1.2

5.14

14.51

u/l

—

Other degenerative diseases of the nervous system

462

1.10

0.29

1.2

29.08

27.75

u/l

0.05

398

Other diseases of spinal cord

1.25

0.29

1.7

1.1

49.00

17.45

u/l

—

Pregnancy hypertension

111

932

1.07

0.29

1.2

14.62

20.53

u/l

1.82

102

808

Migraine without aura and triptan purchases

326

1.14

0.28

1.1

1.2

11.60

20.47

u/l

1.60

287

Parkinson's disease, including avohilmo

302

0.86

0.28

1.4

1.2

20.10

25.64

u/l

0.34

253

Hypertrophy of breast

431

1.11

0.28

1.1

1.2

13.40

20.89

u/l

0.95

372

Type of accident

617

0.91

0.28

1.2

45.23

21.78

u/l

1.42

523

Alzheimer’s disease (Early onset), excluding more controls

1.28

0.28

1.1

1.2

10.38

21.81

u/l

—

Complications predominantly related to the puerperium

626

0.91

0.27

1.4

1.2

14.39

20.14

u/l

1.25

546

Menorrhagia

112

579

1.07

0.26

1.2

23.32

22.88

u/l

0.03

101

495

Serous carcinoma of ovary

0.69

0.26

1.6

1.2

23.60

14.87

u/l

—

Specific development disorders of speech and language

0.67

0.26

1.2

19.40

10.79

u/l

—

Inguinal hernia, bilateral

181

0.83

0.25

2.0

1.3

30.73

24.30

u/l

0.20

149

Other noninflammatory disorders of uterus, except cervix

499

1.08

0.25

1.2

20.21

20.68

u/l

0.05

420

Colorectal cancer

502

1.10

0.25

1.1

1.2

43.79

25.62

u/l

0.73

419

Additional codes for the location of defect, injury or illness

1.25

0.24

1.3

1.2

15.50

16.55

u/l

0.09

Hypertrophy of breast in women and men

484

1.10

0.24

1.2

13.53

20.75

u/l

1.05

418

Alzheimer disease, excluding more controls

241

0.89

0.24

1.2

27.17

28.69

u/l

0.05

206

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

275

0.87

0.23

1.0

1.1

17.22

20.50

u/l

0.25

230

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

1.28

0.23

1.0

1.2

13.20

16.33

u/l

—

Nontoxic goitre/thyroid nodule

824

1.07

0.22

1.2

9.81

23.16

u/l

9.60

697

Secondary polycythaemia

1.25

0.22

1.0

1.2

14.60

12.76

u/l

—

Mandibular retrognathia

0.73

0.22

1.0

1.1

35.86

22.85

u/l

—

Manic episode

1.19

0.21

1.4

1.2

41.00

13.46

u/l

—

Lichen sclerosus et atrophicus

220

0.86

0.21

1.2

12.21

19.09

u/l

1.15

184

Unknown and unspecified causes of morbidity

103

0.78

0.21

1.8

1.1

28.50

14.29

u/l

—

Moderate visual impairment, binocular

1.16

0.21

1.2

12.60

15.11

u/l

—

therapeutic use

1.23

0.20

1.7

1.1

44.33

15.83

u/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.23

0.20

1.7

1.2

25.33

14.51

u/l

—

Other disorders of prostate

1.23

0.20

1.3

1.1

38.33

20.08

u/l

—

Parkinson's disease

292

0.89

0.20

1.4

1.2

20.10

26.12

u/l

0.38

245

Dislocation, sprain and strain of joints and ligaments of knee

139

1351

0.96

0.19

1.3

1.2

18.79

22.27

u/l

0.62

126

1159

Viral infections of the central nervous system

127

1.18

0.19

1.3

1.1

8.67

22.76

u/l

1.13

110

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

137

1.17

0.18

1.2

15.94

19.62

u/l

0.17

118

Chondromalacia

1.13

0.18

1.0

1.2

49.33

16.04

u/l

—

Inguinal or femoral hernia, bilateral

185

0.86

0.18

2.0

1.3

32.25

24.01

u/l

0.29

152

Parkinson's disease, strict definition

269

0.89

0.18

1.5

1.2

20.74

24.50

u/l

0.21

226

Noninflammatory disorders of female genital tract

117

618

0.95

0.18

1.2

25.72

22.09

u/l

0.19

104

531

Supplementary factors related to causes of morbidity and mortality classified elsewhere

662

0.94

0.18

1.2

45.90

21.63

u/l

1.58

560

Blepharochalasis

785

0.94

0.17

1.3

1.2

21.26

22.44

u/l

0.08

670

Other obstetric trauma

1.22

0.17

1.3

1.2

20.20

24.64

u/l

—

Maltreatment syndromes

0.76

0.17

1.4

1.1

7.60

14.65

u/l

—

Benign neoplasm: Skin, unspecified

1.13

0.16

1.4

1.2

12.75

18.16

u/l

—

Alzheimer’s disease (Early onset)

1.11

0.16

1.1

1.2

10.37

27.07

u/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

126

1058

1.04

0.16

1.2

14.73

20.20

u/l

1.75

117

913

Scleritis and episcleritis

111

1.17

0.15

1.3

1.1

18.00

20.36

u/l

0.13

Normal-pressure hydrocephalus

0.79

0.15

1.0

1.2

18.50

20.27

u/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1025

0.96

0.15

1.3

1.2

36.28

21.18

u/l

0.91

873

1.12

0.15

1.6

1.1

30.78

19.57

u/l

—

Glaucoma, exfoliation

213

0.89

0.15

1.2

43.57

23.86

u/l

0.65

173

Benign lipomatous neoplasm

595

1.06

0.15

1.1

1.2

13.59

20.32

u/l

1.77

498

Pre-eclampsia or eclampsia

537

1.06

0.14

1.3

1.2

15.83

20.88

u/l

0.84

457

Polycystic ovarian syndrome, broad definition

139

0.86

0.14

1.2

22.33

20.28

u/l

0.08

120

Gestational [pregnancy-induced] hypertension

551

0.94

0.14

1.1

1.2

11.63

19.60

u/l

2.59

472

Other acquired deformities of musculoskeletal system and connective tissue

1.19

0.14

1.3

1.1

27.40

17.01

u/l

—

Other condition

266

1.09

0.14

1.2

66.21

22.41

u/l

1.41

224

Hydrocele

199

1.11

0.13

1.1

1.3

35.56

23.54

u/l

0.49

161

Ectopic pregnancy

458

0.94

0.13

1.1

1.2

13.08

16.57

u/l

0.73

390

Alzheimer’s disease (Late onset), excluding more controls

189

0.92

0.12

1.2

37.47

29.11

u/l

0.26

158

Schizophrenia

324

0.93

0.12

1.0

1.2

13.52

21.12

u/l

1.04

277

Primary open-angle glaucoma

774

0.96

0.12

1.2

26.48

26.31

u/l

0.01

654

Varicose veins

179

1390

0.97

0.12

1.3

1.2

27.74

24.17

u/l

0.39

149

1187

Tinnitus

600

1.05

0.12

1.3

1.2

18.43

23.59

u/l

0.60

501

Disorders of refraction and accommodation

559

1.05

0.12

1.3

1.2

15.02

20.08

u/l

0.91

477

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

124

1.13

0.11

1.4

1.2

19.50

16.13

u/l

0.21

104

Colorectal adenocarcinoma

387

1.06

0.10

1.1

1.2

52.06

25.29

u/l

0.82

322

Supervision of high-risk pregnancy

287

1.05

0.10

1.1

1.3

26.73

17.34

u/l

0.26

255

Propionic acid derivatives

372

0.96

0.10

1.1

1.2

26.54

24.54

u/l

0.09

339

Use of levodopa decarboxylase inhibitor

251

1.08

0.10

1.4

1.2

20.81

26.15

u/l

0.34

209

Oral lichen ruber planus

1.09

0.09

1.4

1.1

95.40

14.15

u/l

—

Adenocarcinoma of pancreas

1.09

0.09

1.4

1.3

28.60

20.00

u/l

—

Schizophrenia, schizotypal and delusional disorders

713

1.04

0.09

1.1

1.2

13.67

20.30

u/l

1.68

613

Spontaneous abortion

122

853

0.97

0.09

1.2

13.51

19.82

u/l

2.52

111

735

Other facial nerve disorders

1.04

0.09

1.0

1.1

7.80

15.19

u/l

—

Presbyopia

116

1.12

0.09

1.1

1.2

14.00

20.74

u/l

0.57

Artificial joint operation, meniscal resection

262

1774

0.98

0.09

1.2

21.71

26.31

u/l

1.22

224

1527

Disorder of external ear, unspecified

1.09

0.09

1.3

1.1

14.67

16.00

u/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

219

1455

1.02

0.08

1.2

16.62

22.42

u/l

1.79

188

1263

Triptan medication for migraine, single purchase ok

219

1455

1.02

0.08

1.2

16.62

22.42

u/l

1.79

188

1263

Impingement syndrome of shoulder

587

1.04

0.08

1.1

1.3

25.87

21.32

u/l

0.33

509

Antenatal screening

300

0.96

0.08

1.2

1.3

8.57

17.57

u/l

6.25

267

Subacute thyroiditis

0.82

0.08

1.2

1.1

27.80

15.84

u/l

—

Placenta praevia

0.82

0.08

1.6

1.2

8.20

17.18

u/l

—

Allergic rhinitis

660

1.04

0.08

1.3

1.2

22.13

18.68

u/l

0.20

572

Systemic atrophies primarily affecting the central nervous system

1.09

0.08

1.1

1.2

13.29

17.88

u/l

—

Failed induction of labour

1.08

0.08

1.0

1.2

7.57

29.71

u/l

—

Other female pelvic inflammatory diseases

408

0.96

0.07

1.3

1.2

15.97

19.62

u/l

0.39

346

Bicipital tendinitis

0.83

0.07

1.0

1.2

34.14

17.68

u/l

—

Other benign neoplasms of skin

956

1.03

0.07

1.3

1.2

20.23

23.65

u/l

0.46

805

Benign neoplasm: Skin of eyelid, including canthus

334

1.05

0.06

1.2

12.79

20.75

u/l

1.65

283

Impacted teeth

237

0.94

0.06

1.2

9.75

19.62

u/l

1.52

208

Other menopausal disorders

511

1.03

0.06

1.2

19.89

22.45

u/l

0.17

433

Nontoxic multinodular goitre

492

1.04

0.06

1.2

9.12

20.63

u/l

7.73

416

Postpartum haemorrhage due to anatomy

111

0.90

0.06

1.4

1.2

6.00

18.26

u/l

—

Parkinson's disease, excluding more controls

240

1.06

0.06

1.4

1.3

20.10

26.04

u/l

0.39

203

Other maternal disorders predominantly related to pregnancy

157

1003

0.98

0.05

1.2

17.53

20.73

u/l

0.69

145

864

Schizophrenia or delusion

713

1.02

0.05

1.1

1.2

12.13

20.31

u/l

3.10

613

Contraceptive management

108

747

1.02

0.04

1.4

1.2

19.16

21.10

u/l

0.16

649

Alzheimer’s disease, wide definition, excluding more controls

205

0.96

0.04

1.2

25.36

27.73

u/l

0.07

172

Parkinson's disease, strict definition, excluding more controls

225

1.05

0.04

1.5

1.3

20.74

25.37

u/l

0.27

191

Other benign neoplasms of connective and other soft tissue

190

1.05

0.04

1.4

1.2

15.27

18.60

u/l

0.40

165

Maternal care for known or suspected abnormality of pelvic organs

384

1.02

0.03

1.3

1.2

13.85

18.03

u/l

0.45

339

Other hearing loss

652

0.98

0.03

1.1

1.2

25.37

27.76

u/l

0.15

542

Medical treatment for female infertility

358

1.03

0.03

1.4

1.2

15.91

19.97

u/l

0.33

314

Female infertility, associated with anovulation

1.09

0.03

1.2

1.3

11.60

19.06

u/l

—

Dental caries 2, only avohilmo

200

1565

1.01

0.02

1.3

1.2

20.42

21.29

u/l

0.12

173

1352

Pregnancy with abortive outcome

199

1033

1.01

0.02

1.2

26.01

21.22

u/l

0.39

171

888

Episcleritis

1.08

0.02

1.4

1.1

14.30

15.25

u/l

—

Other disorders of eyelid

122

1169

1.01

0.01

1.2

23.95

24.58

u/l

0.05

104

992

Triptan medication for migraine, min. 3 purchases

141

1120

0.99

0.01

1.1

1.2

17.83

20.06

u/l

0.33

120

978

Injury of muscle and tendon at shoulder and upper arm level

828

0.99

0.01

1.2

35.04

22.54

u/l

0.73

687

Pre-eclampsia or poor fetal growth

682

1.01

0.00

1.3

1.2

15.10

19.69

u/l

0.96

592

Excessive vomiting in pregnancy

142

0.99

0.00

1.1

17.29

23.44

u/l

0.28

126

Inguinal hernia

131

886

1.00

0.00

1.3

1.2

21.58

28.13

u/l

0.98

110

754

Benign neoplasm of meninges

215

1.02

0.00

1.6

1.2

19.41

20.51

u/l

0.07

185

Primary open-angle glaucoma, strict

621

1.00

0.00

1.2

24.90

24.86

u/l

0.00

511

Dental caries 1 and operation codes, only avohilmo

381

1.00

0.00

1.1

1.3

18.08

28.26

u/l

1.79

345

Later onset COPD

459

1.01

0.00

1.2

1.3

28.02

30.77

u/l

0.21

389

Supervision of normal pregnancy

290

1.01

0.00

1.2

1.3

12.63

17.62

u/l

1.08

260

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

244

0.98

0.00

1.0

1.1

17.22

20.37

u/l

0.25

205

Infectious mononucleosis

114

0.96

0.00

1.0

1.3

15.36

26.44

u/l

0.47

102

Chronic suppurative otitis media

113

0.97

0.00

1.5

1.1

21.45

17.41

u/l

0.22

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.0

1.0

—

8.00

—

Birth asphyxia

0.00

0.0

1.0

—

9.80

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.93

0.00

1.6

1.1

23.60

19.27

u/l

—

Slow fetal growth and fetal malnutrition

0.00

0.0

1.0

—

11.50

—

Congenital malformations of larynx

0.00

0.0

1.0

—

19.40

—

Congenital malformations of eye, ear, face and neck

0.96

0.00

1.1

15.44

16.37

u/l

—

Other congenital malformations of heart

0.00

0.0

1.1

—

7.75

—

Placental disorders

0.00

0.0

1.1

—

12.75

—

Benign neoplasm: Larynx

0.93

0.00

1.0

1.2

7.40

17.45

u/l

—

Pityriasis lichenoides chronica

0.00

0.0

1.0

—

20.40

—

Endometriosis ASRM stages 3,4

570

1.00

0.00

1.3

1.2

35.86

20.15

u/l

0.47

487

Typhoid and paratyphoid fevers

0.00

0.0

1.5

—

17.17

—

Benign neoplasm: Other and unspecified parts of mouth

0.98

0.00

1.5

1.2

33.33

18.35

u/l

—

Impacted maxillary canine

0.00

0.0

1.0

—

18.83

—

Abnormal findings on diagnostic imaging of central nervous system

0.99

0.00

1.3

1.2

54.00

16.19

u/l

—

Vascular dementia (other)

0.00

-0.00

0.0

1.0

—

21.86

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS